<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-3026027584095932250</id><updated>2012-01-26T21:50:38.929-09:00</updated><category term='Antisense therapy'/><category term='RNA Molecules Custom Peptide   Synthesis'/><category term='antigen/antibody'/><category term='DNA To RNA'/><category term='Amino Acid Analysis Profile'/><category term='Peptide'/><category term='Apoptosis antagonizing transcription factor'/><category term='genetic code'/><category term='Carbohydrate-oligonucleotide Conjugates'/><category term='RNA-Binding Proteins'/><category term='Commerical Microarray'/><category term='Peptide Drug'/><category term='Peptide Carrier Protien Conjugation'/><category term='Custom Peptide Synthesis Services'/><category term='DNA Microarray'/><category term='Peptide Library'/><category term='Custom Oligonucleotide Microarray'/><category term='Sectioning'/><category term='Custom Bioconjugations'/><category term='Custom Antibody Synthesis'/><category term='Oligo Nucleotide'/><category term='Antisense oligonucleotides'/><category term='RNA Extraction'/><category term='Antigen Processing'/><category term='Anti DNA Antibody.'/><category term='Family Tree DNA DNA and Labeling Techniques'/><category term='Biopolymer Conjugation'/><category term='Antibody Peptide'/><category term='RNA Synthesis'/><category term='Peptide Synthesis'/><category term='Custom Organic Synthesis'/><category term='pna-dna'/><category term='Parental Testing'/><category term='PCR Primer Design'/><category term='serum proteins'/><category term='DNA Testing'/><category term='Specialty Peptide Manufacturers'/><category term='Quality Design Peptide Product'/><category term='antibodies'/><category term='DNA'/><category term='Medical Genetics'/><category term='PNA Chimera'/><category term='RNAi Pathway'/><category term='RNA interference'/><category term='Signalling Molecules'/><category term='Brain Natriuretic Peptides'/><category term='Molecular Basis'/><category term='Antisense DNA'/><category term='Relationship DNA Testing'/><category term='PNA Conjugates'/><category term='Enzyme Bioconjugation'/><category term='Forensic Science'/><category term='Home Paternity Testing'/><category term='Custom Bioconjugation'/><category term='RNA Gene Silencing'/><category term='epigenetic'/><category term='ACV and Related Compounds'/><category term='Oligonucleotide'/><category term='Oligonucleotide synthesis'/><category term='dna evidence'/><category term='DNA Structure'/><category term='Epitope'/><category term='RNA Hybrid'/><category term='Specialty Peptide Synthesis'/><category term='Oligo Microarray'/><category term='antibody synthesis'/><category term='ATR Antibody'/><category term='Molecular Biology Division'/><category term='Anthrax LF'/><category term='Conjugation of Toxins'/><category term='DNA Chimera'/><category term='epigenetic code'/><category term='Phosphospecific Antibody Production'/><category term='Ribonucleic Acid'/><category term='Custom Bioconjugation Services'/><category term='DNA Synthesis'/><category term='DNA Chain Terminators'/><category term='Custom Synthesize'/><category term='Peptide Sequence Selection'/><category term='DNA double helix'/><category term='Custom Peptide Antibody Production'/><category term='DNA Strand Hypothesis'/><category term='Anthrax PA'/><category term='DNA RNA Standard'/><category term='Double Stranded Oligo'/><category term='DNA Strands'/><category term='Conjugation'/><category term='Hybrid Genetics'/><category term='Cell Line Authentication Services'/><category term='Anthrax PA Antibody'/><category term='DNA Protein Synthesis'/><category term='Free DNA Paternity Testing'/><category term='pna-RNA'/><category term='Multiple Antigen Peptide'/><category term='bioconjugation expert'/><category term='Custom Long Peptide Synthesis'/><category term='Biological Agents'/><category term='Antibiotic Peptides.'/><category term='Custom LNA Synthesis'/><category term='DNA Chimeras'/><category term='Labeling of Duplex DNA'/><category term='FITC-labeled antibodies'/><category term='Peptide Services'/><category term='Amino acid synthesis'/><category term='RNA Research Analysis'/><category term='Protein Carrier Conjugation'/><category term='DNA Testing Services'/><category term='Antibody Packages'/><category term='STR Identity Profile'/><category term='RNA Separation'/><category term='DNA Methylation'/><category term='Antisense mRNA'/><category term='PNA Conjugations'/><category term='Array Chip Printing'/><category term='Antigen Peptide Conjugation'/><category term='Peptide Microarray'/><category term='Amino Protein'/><category term='Peptide Quantities'/><category term='Modified RNA'/><category term='inhalation'/><category term='biochemical techniques'/><category term='Clone Antibody'/><category term='Conjugated Peptide'/><category term='Genetics'/><category term='Array Processing'/><category term='Antibody Conjugation'/><category term='DNA Synthesis Primer'/><category term='Ribosomal RNA Primers'/><category term='Therapeutic Peptide'/><category term='Custom DNA   Synthesis'/><category term='monoclonal antibodies'/><category term='lipid'/><category term='Antibody'/><category term='albumin'/><category term='Allelic architecture of disease'/><category term='antibody fragments'/><category term='Unmodified RNA'/><category term='Custom Peptide Library'/><category term='Heterophile Antibody'/><category term='PNA Chimeras'/><category term='RNA Oligonucleotide Synthesis'/><category term='pna-oligo'/><category term='RNA product'/><category term='Quality Design Peptide'/><category term='Nucleotides'/><category term='siRNAs'/><category term='Modification process of Nucleic Acids'/><category term='DNA vs. RNA'/><category term='Conjugate of Small Molecular'/><category term='Ribosomal RNA Analysis'/><category term='Antibody Production'/><category term='Custom Oligonucleotide'/><category term='oligonucleotides'/><category term='DNA Acridine Complexes'/><category term='Antibody conjugates'/><category term='Transcription'/><category term='Antisense'/><category term='PNA'/><category term='DNA Transcription'/><category term='Custom Synthesis Projects'/><category term='Custom   DNA Synthesis'/><category term='Custom siRNA Synthesis'/><category term='ntibody production'/><category term='DNA Analysis'/><category term='Custom PNA Systhesis'/><category term='Antibody Peptide Carrier'/><category term='Research Bioconjugates'/><category term='LNA Oligo Synthesis'/><category term='Essential Amino Acids'/><category term='STR DNA Typing'/><category term='Custom Oligo Spotted Array'/><category term='Peptide Synthesis Long'/><category term='DNA Binding Proteins'/><category term='Toxin Conjugates'/><category term='Trojan Peptides'/><category term='Cross Linking Small Molecule'/><category term='DNA Amino Modifiers'/><category term='Chains Terminator Salvation'/><category term='RNA Chimera'/><category term='Bioconjugates Oligonucleotide'/><category term='Lipid-oligonucleotide Conjugates'/><category term='haptoglobin'/><category term='Biopolymer Small Molecule Labeling'/><category term='Epitopes'/><category term='Alpha DNA'/><category term='Bioconjugation Service'/><category term='DNA Testing Procedure'/><category term='Custom Microarray Services'/><category term='Peptide Arrays'/><category term='Protein Peptide Service'/><category term='polyclonal antibody'/><category term='STR DNA Identification'/><category term='Peptide Nucleic Conjugation'/><category term='Array Processing Services'/><category term='Anthrax Protective Antigen Antibody'/><category term='Athrax PA'/><category term='Custom Peptide Production'/><category term='Custom Antibody Custom Peptide Synthesis Custom SiRNA Synthesis'/><category term='Labelling Proteins'/><category term='Biologically Active Peptides'/><category term='Custom DNA SynthesisCustom Antibody SynthesisCustom Peptide Synthesis&apos;Custom Constrained Nucleotide SynthesisCustom RNA SynthesisCustom PNA Synthesis'/><category term='LNA Chimeras'/><category term='Commercial Microarray Platforms'/><category term='RNA Processing'/><category term='Custom Antibody   Synthesis'/><category term='Antibody Diagnostics'/><category term='immunohistochemistry'/><category term='Chain Terminators'/><category term='Antibiotic Peptides'/><category term='KLH Conjugation'/><category term='Custom PNA   Synthesis'/><category term='Custom PNA Bioconjugation'/><category term='PNA Synthesis'/><category term='Anthrax toxin receptor'/><category term='RNA Polymerases'/><category term='Amylin Peptides'/><category term='RNA'/><category term='Peptide PNA'/><category term='Array RNA Amplification Spotted Arrays'/><category term='DNA Polymerase'/><category term='DNA micro arrays'/><category term='RNA Genetics'/><category term='Amino Acid'/><category term='Single Strand Binding Protein'/><category term='LNA'/><category term='Amino Acid Serum'/><category term='Protein Profile'/><category term='Multiplex STR Technology'/><category term='DNA Sequence Analysis'/><category term='Microarray Services'/><category term='Design Peptide Product'/><category term='DNA Repair'/><category term='DNA-RNA-Protein'/><category term='Small Molecule'/><category term='PEG Polymer Conjugate'/><category term='DNA Typing'/><category term='Locked Nucleic Acid'/><category term='Oligo Synthesis and gene synthesis'/><category term='Non-Essential Amino Acid'/><category term='LNA Oligos'/><category term='edema factor'/><category term='Custom Antibody Peptide Carrier'/><category term='Quantity Peptide Synthesis'/><category term='Anthrax Edema Factor'/><category term='Methylphosphonate'/><category term='Luminex Assay Services'/><category term='Protein Peptide Sequencing'/><category term='Isotypes'/><category term='PEG polymer'/><category term='DNA Test For Free'/><category term='Extinct Biological Hazard Organisms'/><category term='bioconjugation chemistry'/><category term='Custom Peptide Synthesis'/><category term='Acinus Antibody'/><category term='Legal DNA Tests'/><category term='Recombinant DNA'/><category term='Introduction to Swine Flu'/><category term='DNA Acridine'/><category term='Home DNA Testing'/><category term='Anthrax Lethal Factor'/><category term='RNA Microarray'/><category term='Carrier Conjugation'/><category term='Biological Hazard'/><category term='RNA Replication'/><category term='Synthesis Long'/><category term='Amino Acid Analysis Services'/><category term='Microarrays'/><category term='PNA-peptides'/><category term='Custom Antibody'/><category term='lethal factor'/><category term='Nucleic Acid Hybridization'/><category term='PNA Peptide Conjugation'/><category term='cell culture contamination'/><category term='cell line contamination'/><category term='Protein Synthesis'/><category term='Ribosomal RNA'/><category term='Influenza Peptide Virus'/><category term='Biosyn'/><category term='LNA Conjugations'/><category term='modified oligos'/><category term='epigenetic research'/><category term='Synthetic Peptides'/><category term='DNA/Constrained Nucleotide Oligonucleotides Hybridized'/><category term='Specialty Peptide'/><category term='conjugation of peptides'/><category term='Anthrax lethal factor antibody'/><category term='porteins'/><category term='Produce Peptide'/><category term='DNA Replication'/><category term='Acinus'/><category term='Peptide Synthesis Services'/><category term='Immobilization System'/><category term='Forensic DNA'/><category term='Speciality Peptide Synthesis'/><category term='Custom RNA'/><category term='Synthesis'/><category term='Double-Stranded DNA Molecule'/><category term='Mitochondrial DNA (mtDNA) testing'/><category term='Peptides'/><category term='Protein'/><category term='Cosmetic Peptides'/><category term='RNA Assay'/><category term='DNA Paternity Testing'/><category term='Nomenclature'/><category term='Antigen Peptide'/><category term='AATF Antibody'/><category term='Peptide Library Synthesis'/><category term='Bioconjugates'/><category term='Specialty Peptide Synthesis Long'/><category term='Amino acids and DNA'/><category term='serum'/><category term='Peptide Ligands'/><category term='Ribosomes'/><category term='DNA Test'/><category term='epigenetic marks'/><category term='DNA strand'/><category term='Small Interfering RNA'/><category term='GMP Peptide Manufacturing'/><category term='RNA Catalysis'/><category term='Gastric Inhibitory Peptides'/><category term='protective antigen'/><category term='Anti DNA Antibody'/><category term='Use of Synthetic Peptides'/><category term='Amino Structure'/><category term='Microarray Analysis'/><category term='Eukaryotes'/><category term='contaminated cell lines'/><category term='DNA Nanotechnology'/><category term='Adoption DNA Testing'/><category term='Peptide-oligonucleotide Conjugates'/><category term='Custom RNA Synthesi'/><category term='Cross Linking'/><category term='Produce Peptide Quantities'/><category term='Peptide Molecule Synthesis'/><category term='Peptide Sequencing Service'/><category term='anti-peptide antibodies'/><category term='RNA Conjugations'/><category term='PNA-oligomers'/><category term='transferin'/><category term='Synthesis substrates'/><category term='DNA Familial Relationship Tests'/><category term='Contract Peptide Synthesis'/><category term='Custom Microarray'/><category term='Immunogen Conjugates'/><category term='Oligopeptide Laboratory'/><category term='Protein RNA'/><category term='Peptide Antigens'/><category term='Anti Peptide Antibodies'/><category term='Conjugation Services'/><category term='Array Related Service'/><category term='DNA and Chromosomes'/><category term='Anthrax Protective Antigen'/><category term='Antipeptide Antibody Production'/><category term='Peptide in Beauty Industry'/><category term='Acridine Orange'/><category term='pna-oligonucleotide'/><category term='Custom RNA Synthesis'/><category term='RNA Research Analysis Custom Peptide Synthesis'/><category term='RNA Resources'/><category term='Organic Laboratory Technique'/><category term='Antisense Oligos'/><category term='RNA Molecules'/><category term='Antisense molecules'/><category term='Antibody Structure'/><category term='Custom   Antibody Synthesis'/><category term='Free DNA Paternity Test'/><category term='Custom Oligos'/><category term='Protein Conjugation'/><category term='Custom Conjugation'/><category term='Opioid Receptor Ligands'/><category term='Peptide Applications'/><category term='Peptide Nucleic Acid'/><category term='Protein biosynthesis'/><category term='DNA Mutations'/><category term='amino acids'/><category term='RNA Electrophoresis'/><category term='Commercial Array Processing'/><category term='Human Anthrax PA'/><category term='Custom DNA Synthesis'/><category term='SIRNA Synthesis'/><category term='Immobilization Techniques'/><category term='Blast Biosyn Pepidebody'/><category term='Polypeptide'/><category term='antigens'/><category term='PEG Advantage'/><category term='mRNA sequence'/><category term='PNA/DNA chimera'/><category term='Custom PNA Synthesis'/><category term='DNA Amino'/><category term='DNA Methylation in Humans'/><category term='Amino Acid Analysis Composition'/><category term='anti-aging products'/><category term='Home DNA Paternity Tests'/><category term='GMP Peptides Synthesis'/><category term='Oligonucleotide Microarray'/><category term='DNA sequencing'/><category term='Genetics RNA'/><category term='Custom Constrained Nucleotide Synthesis'/><category term='alpha -antitrypsin'/><category term='Specialty Peptide Synthesis MAP'/><category term='misidentified cell lines'/><category term='epigenetic factors'/><category term='amino acid sequence'/><category term='Immobilizing Biopolymer'/><category term='Sequential synthesis'/><category term='DNA Hybridization'/><category term='HIV Epitope'/><category term='Amino Acid Analysis Protein'/><category term='siRNA'/><category term='Polypepti'/><category term='Phosphospecific Antibody'/><category term='beauty'/><category term='GFR alpha 3 Antibody'/><category term='RNA DNA Duplex'/><category term='epigenetic changes'/><category term='DNA Testing Centers'/><category term='Use of Oligonucleotides'/><category term='Common RNA'/><category term='bioconjugation'/><category term='Bioconjugates Properties'/><category term='Forensic Paternity Test'/><category term='DNA-Binding Proteins'/><category term='Ribsomal RNA Services'/><category term='Custom Chemical Synthesis'/><category term='Custom Peptides'/><category term='Nucleic Acid Synthesis'/><category term='Modern Organic Synthesis'/><category term='Contract Peptide'/><category term='Peptide Mapping Service'/><category term='Synthetic Peptide'/><category term='Amyloid Beta Peptides'/><category term='Acridine Complexes'/><category term='DNA Structure Animation'/><category term='RNA Cell'/><category term='Peptide Carrier'/><category term='Antibody Conjugation Services'/><category term='Amino Modifiers'/><category term='Bioconjugations'/><category term='DNA Exam'/><category term='Peptide Array'/><category term='epigenetic disorder'/><category term='Peptide Nucleic Acids'/><category term='Nucleic Acid Conjugations'/><category term='Polymer Bioconjugation Services'/><title type='text'>BIO-SYNTHESIS - Custom Antibody Custom Peptide Synthesis Custom SiRNA Synthesis</title><subtitle type='html'>BIO-SYNTHESIS, INC. is a leading life science products company with over 20 years of experience in the design and synthesis of Custom Peptide, small molecules and reagents for small scale research and bulk pharmaceutical trials. Using state of the art technology in our well-equipped laboratories.</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://blog.biosyn.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default?start-index=101&amp;max-results=100'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>1539</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-8919986316313948099</id><published>2011-08-30T14:22:00.002-08:00</published><updated>2011-08-30T15:03:04.454-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Peptide Applications'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Biologically Active Peptides'/><category scheme='http://www.blogger.com/atom/ns#' term='Synthetic Peptides'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>Large Scale Custom Peptide Synthesis</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/large_scale_custom_peptide_synthesis.aspx"&gt;&lt;span style="font-weight: bold;"&gt;Large Scale Custom Peptide Synthesis&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;Bio-Synthesis&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; has been producing synthetic peptides for over 25 years. Our expertise in custom synthetic polypeptide manufacturing allows us to produce the high-quality, large-scale, and GMP &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;peptides&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; with the highest success rate with long standing records. We have been delivered more than 100,000 peptides to customers worldwide, including very hydrophobic polypeptide, peptide with multiple disulfide bonds, multi-phosph0rylated peptides and extremely long peptides. Our large scale non-GMP ever delivered 5 kilograms of peptides on a single order and has the capacity of 10,000 peptides per month. Our capacity of GMP peptide is 10 kilograms.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Peptide Applications&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Peptide applications play an important role in biochemistry, molecular biology, immunology and medicine. In the human body, most if not all biological/physiological processes are regulated by various forms of molecular recognition. Most of these processes involve initiation or inhibition trough protein-protein interaction. As we know peptides and proteins due to the vast number of conformational possibilities are ideal to carry out such complex control functions. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Use of Synthetic Peptides&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;Synthetic peptides&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; have been widely used for many purposes like: structure-function studies of polypeptides, as peptide hormones and hormone analogues, in the preparation of cross-reacting antibodies, in the design of novel enzyme and in drug discovery.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Biologically Active Peptides&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The last 40 years have seen an enormous growth in the methodologies available to obtain peptide and protein molecules. Through recombinant methods, most labs can now assemble genes, subcloned into expression vectors and obtain a wide range of endogenous proteins; likewise the pioneering work of Bruce Merrifield, makes it possible to obtain large scale with multikilo amounts of a number of biologically active &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;peptides.&lt;/a&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-8919986316313948099?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/8919986316313948099/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=8919986316313948099' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/8919986316313948099'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/8919986316313948099'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/large-scale-custom-peptide-synthesis.html' title='Large Scale Custom Peptide Synthesis'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-5559333901962577672</id><published>2011-08-30T14:11:00.004-08:00</published><updated>2011-08-30T14:20:46.304-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>LKB1 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/LKB1_Antibody-4098.aspx"&gt;&lt;span style="font-weight: bold;"&gt;LKB1 Antibody&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:3987&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The LKB1 serine/threonine protein kinase was initially identified as a tumor suppressor gene mutated in human Peutz-Jeghers syndrome (PJS), a condition resulting in the growth of numerous intestinal polyps classed as hamartomas. LKB1 exists as a heterotrimeric complex with two other proteins, Ste20-related adaptor protein (STRAD) and MO25. Together, this complex can phsophorylate and activate the AMP-activate protein kinase (AMPK). Following AMPK activation by LKB1, AMPK then phosphorylates TSC1 and TSC2, key components of the metabolism-regulating TOR signaling pathway, which antagonizes the activation for the TOR pathway. LKB1 has also been shown to play a fundamental role in controlling the spatial orientation of structures required to maintain an ordered, polarized epithelium. LKB1 often migrates at a higher than expected molecular weight in SDS-PAGE.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;LKB1, Serine-threonine protein kinase 11, STK11, NT-REN-19 antigen&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C3987.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 161px; height: 175px;" src="http://www.biosyn.com/Images%5Cantibody%5C3987.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;b style="font-family: verdana;"&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Western blot  analysis of LKB1 in PC-3 cell lysate with LKB1 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at 1 µg/ml in  the (A) absence or (B) presence of blocking peptide.                                                                              &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;LKB1 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a 15 amino acid &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; from near the carboxy terminus of human LKB1.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Affinity chromatography purified via peptide column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;LKB1 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; LKB1 antibody can be used for detection of LKB1 by Western blot at 0.5 – 1 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s):&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; E, WB&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat.No. 3987P - LKB1 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; LKB1 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. Cat. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;No. 1216 - PC-3 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;H, M&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;17939640&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; AAH19334&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Serine-threonine protein kinase 11&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;  1.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391:184-7.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   2. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Boudeau J, Baas AF, Deak M, et al. MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J. 2003; 22:5102-14.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;  &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt; 3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Hawley SA, Boudeau J, Reid JL, et al. Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2003; 2:28&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;                                          &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-5559333901962577672?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/5559333901962577672/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=5559333901962577672' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5559333901962577672'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5559333901962577672'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/lkb1-antibody.html' title='LKB1 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-3131568841309932232</id><published>2011-08-30T14:03:00.003-08:00</published><updated>2011-08-30T14:10:02.680-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>KINDLIN3 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/KINDLIN3_Antibody-4618.aspx"&gt;&lt;span style="font-weight: bold;"&gt;KINDLIN3 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:4797&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The three KINDLINs are a novel family of focal adhesion proteins, localizing to integrin adhesion sites. The KINDLIN proteins are composed of a centrally located FERM domain interrupted by a pleckstrin homology (PH) domain. KINDLIN1 and KINDLIN2 have been shown to play an essential role in integrin-mediated adhesion and spreading. In contrast to the widely expressed KINDLIN1 and KINDLIN2, KINDLIN3 is restricted to hematopoietic cells and is particularly abundant in megakaryocytes and platelets. Several reports describe a transcriptional misregulation of KINDLINs in various types of cancer. A recent study demonstrates that KINDLIN3 is essential for platelet integrin activation and subsequent integrin outside-in signaling, suggesting it may serve as a potential target for the design of therapeutics aimed at specifically disrupting integrin activation in platelets and leukocytes.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;KINDLIN3, Fermitin family homolog 3, FERMT, Unc-112-related protein 2, MIG2-like protein, KIND3, MIG2B, URP2&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C4797.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 168px; height: 155px;" src="http://www.biosyn.com/Images%5Cantibody%5C4797.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of KINDLIN3 in rat spleen lysate with KINDLIN3 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at (A) 1 and (B) 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;KINDLIN3 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspxhttp://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a 19 amino acid &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; near the carboxy terminus of the human KINDLIN3.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Affinity chromatography purified via peptide column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;This is a polyclonal antibody.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Host: KINDLIN3 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;KINDLIN3 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for detection of KINDLIN3 by Western blot at 1 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s): &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;E, WB&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat.No. 4797P - KINDLIN3 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; KINDLIN3 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. Cat.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; No. 1466 - Rat Spleen Tissue Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; H, M, R&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;41281905&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; NP_848537&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Fermitin family homolog 3&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   1. Ussar S, Wang HV, Linder S, et al. The Kindlins: subcellular localization and expression during murine development. Exp. Cell Res. 2006; 312:3142-51.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   2. Weinstein EJ, Bourner M, Head R, et al. URP1: a member of a novel family of PH and FERM domain-containing membrane-associated proteins is significantly over-expressed in lung and colon carcinomas. Biochim. Biophys. Acta 2003; 1637:207–16.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   3. Boyd RS, Adam PJ, Patel S, et al. Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B. Leukemia 2003; 17:1605–12.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   4. Mory A, Feigelson SW, Yarali N, et al. Kindlin-3: a new gene involved in the pathogenesis of LAD-III. Blood 2008; 112:2591.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;                                         &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-3131568841309932232?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/3131568841309932232/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=3131568841309932232' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/3131568841309932232'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/3131568841309932232'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/kindlin3-antibody.html' title='KINDLIN3 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-6660799533993261098</id><published>2011-08-30T13:53:00.003-08:00</published><updated>2011-08-30T14:01:58.648-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>KappaB ras2 Antibody</title><content type='html'>&lt;div  style="text-align: center;font-family:verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-weight: bold;" href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/KappaB_ras2_Antibody-4363.aspx"&gt;KappaB ras2 Antibody &lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;:2495&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;KappaB ras-1 (kappaB-ras-1) and kappaB-ras-2 are two small proteins that similar to Ras-like small GTPases that associate with IkappaB (IkappaB), an inhibitor of the transcription factor NF-kappaB. IkappaB exists in two homologous forms, IkappaB-alpha and IkappaB-beta, although IkappaB-beta contains a unique 47-amino acid region within its ankyrin domain. While inactive IkappaB-alpha-NF-kappaB complexes can shuttle in and out of the nucleus, IkappaB-beta-NF-kappaB complexes are retained exclusively in the cytoplasm. It is suggested that kappaB-ras proteins preferentially bind to the IkappaB-beta form through this unique insert within the ankyrin region, thus modulating the cellular location of IkappaB-beta and regulating the rate of degradation of IkappaB-beta. This &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; is specific for kappaB-ras2 and has no cross-reactivity to kappaB-ras1.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div  class="npdet_box2" style="font-family:verdana;"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;KappaB ras2, NF-kappaB inhibitor-interacting Ras like protein 2, kappaB-ras2, NKIRAS2&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C2495.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 166px; height: 174px;" src="http://www.biosyn.com/Images%5Cantibody%5C2495.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt; Western blot  analysis of KappaB ras2 in RAW264.7 cell lysate with KappaB ras1  &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at 1 µg/ml in the (A) absence and (B) presence of blocking  peptide.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;KappaB ras2 antibody was raised against a 14 amino acid &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; from near the carboxy terminus of human KappaB ras2.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification:&lt;/span&gt; Affinity chromatography purified via peptide column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone: &lt;/span&gt;This is a polyclonal antibody.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host: &lt;/span&gt;KappaB ras2 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application: &lt;/span&gt;KappaB ras2 antibody can be used for detection of KappaB ras1 by Western blot at 0.5 – 1 µg/ml.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s):&lt;/span&gt; E, WB&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer:&lt;/span&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat.No. 2495P - KappaB ras2 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; KappaB ras2 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. Cat. &lt;/span&gt;No. 1283 - RAW264.7 Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity:&lt;/span&gt; H, M, R&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number:&lt;/span&gt; 19072794&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; NP_060065&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; NF-kappaB inhibitor-interacting Ras-like protein&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;  1. Fenwick C, Na SY, Voll RE, et al. A subclass of Ras proteins that regulate the degradation of IkappaB. Science 2000; 287:869-73.&lt;br /&gt;  2. Chen Y, Wu J and Ghosh G. KappaB-Ras binds to the unique insert within the ankyrin repeat domain if IkappaBbeta and regulates cytoplasmic retention of IkappaBbeta x NF-kappaB complexes. J. Biol. Chem. 2003; 278:23101-6.&lt;br /&gt;&lt;/span&gt;                                                                                                                                                                                                                                              &lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-6660799533993261098?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/6660799533993261098/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=6660799533993261098' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/6660799533993261098'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/6660799533993261098'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/kappab-ras2-antibody.html' title='KappaB ras2 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-2995190976116700227</id><published>2011-08-22T10:36:00.000-08:00</published><updated>2011-08-22T10:48:19.735-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Bioconjugation Service'/><category scheme='http://www.blogger.com/atom/ns#' term='Bioconjugations'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'></title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Use of Bioconjugates in Apoptosis&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;Bio-Synthesis&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; has acquired years of experience in chemical conjugation of &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;peptides&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;, porteins, oligonucleotides, lipid, bifunctional ligands, antibodies and other biological molecules onto solid surfaces. Our goal is to be your one expert source when seeking new solutions from early drug discovery to delivery.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Bioconjugation Service&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;In some cases the carrier moiety can be a synthetic polymer such as poly-L-glutamic acid to which the drug paclitaxel has been conjugated. The actual mechanism of action is still being elucidated. Another carrier that has been used successfully are the cyclodextrins to which small pro-apoptotic agents can be linked. For example For instance a conjugate of anti-CD33 antibody and the amphipathic peptide KLA target efficiently CD33-positive myeloid leukemia cell lines to cause their apoptotic death induced by the D-(KLAKLAK)2 proapoptotic peptide.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Bioconjugates&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The study of apotosis, the programmed death of cells, has direct applications to cancer a disease where tumor cells have developed mechanisms to avoid it and multiply without control. The fact that apoptosis is usually mediated by some cell receptors makes conjugates a valuable tool in elucidating apoptosis’ mechanisms as well drug development.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Bioconjugations&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Cells over-expressing erbB2 and resistant to apoptosis can be killed more efficiently by a conjugate composed of an erbB2-binding heptapeptide conjugated to the proapoptotic a-tocopheryl succinate (a-TOS) rather than the unconjugated a-TOS. Use of the conjugate resulted in breast carcinomas in a breast cancer prone transgenic mouse strain. Recently it has been shown that conjugates of cytochrome c and &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;oligoarginine&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; linked by a thioether resulted in an increased entry into the cell, compared to cyt. c alone, and increase in apoptotic activity. In contrast a conjugate linked by a disulfide bond although entered into the cell did not enhance the apoptotic activity.&lt;/span&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-2995190976116700227?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/2995190976116700227/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=2995190976116700227' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/2995190976116700227'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/2995190976116700227'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/use-of-bioconjugates-in-apoptosis-bio.html' title=''/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-4039119391020432444</id><published>2011-08-22T10:03:00.000-08:00</published><updated>2011-08-22T10:10:15.999-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='RNA Resources'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='RNA Polymerases'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>RNA Resources</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/rna_resources.aspx"&gt;&lt;span style="font-weight: bold;"&gt;RNA Resources   &lt;/span&gt;  &lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;With over 20 years experience in &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;custom synthesis&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; for the biomedical research communities, BSI has developed the expertise to deliver custom synthesized RNA with quality that meets all your RNAi, siRNA, shRNA and other RNA projects.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;RNA&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Ribonucleic acid or RNA is a nucleic acid made from a long chain of nucleotide units. Each nucleotide consists of a nitrogenous base, a ribose sugar, and a phosphate. RNA is very similar to DNA, but differs in a few important structural details: in the cell RNA is usually single stranded, while DNA is usually double stranded. RNA nucleotides contain ribose while DNA contains deoxyribose (a type of ribose that lacks one oxygen atom), and &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;RNA&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; has the nucleotide uracil rather than thymine which is present in DNA.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;RNA Polymerases&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;RNA is transcribed from DNA by enzymes called RNA polymerases and is generally further processed by other enzymes. Some of these RNA-processing enzymes contain RNA as part of their structures. RNA is also central to the translation of some RNAs into proteins. In this process, a type of RNA called messenger RNA carries information from DNA to structures called ribosomes. These ribosomes are made from proteins and ribosomal RNAs, which come together to form a molecular machine that can read messenger RNAs and translate the information they carry into proteins.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;RNA World Hypothesis&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The RNA world hypothesis proposes that a world filled with RNA (ribonucleic acid) based life predates current DNA (deoxyribonucleic acid) based life. RNA, which can store information like DNA and catalyze reactions like proteins (enzymes), may have supported cellular or pre-cellular life. Some hypotheses as to the origin of life present RNA-based catalysis and information storage as the first step in the evolution of cellular life.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;For more information visit: &lt;/span&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com"&gt;&lt;span style="font-weight: bold;"&gt;www.biosyn.com&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-4039119391020432444?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/4039119391020432444/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=4039119391020432444' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4039119391020432444'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4039119391020432444'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/rna-resources.html' title='RNA Resources'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-4951290962823319322</id><published>2011-08-22T09:58:00.005-08:00</published><updated>2011-08-22T10:02:00.201-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>KappaB ras1 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/KappaB_ras1_Antibody-4362.aspx"&gt;&lt;span style="font-weight: bold;"&gt;KappaB ras1 Antibody&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:2493&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;KappaB ras-1 (kappaB-ras-1) and kappaB-ras-2 are two small proteins that similar to Ras-like small GTPases that associate with IkappaB (IkappaB), an inhibitor of the transcription factor NF-kappaB. IkappaB exists in two homologous forms, IkappaB-alpha and IkappaB-beta, although IkappaB-beta contains a unique 47-amino acid region within its ankyrin domain. While inactive IkappaB-alpha-NF-kappaB complexes can shuttle in and out of the nucleus, IkappaB-beta-NF-kappaB complexes are retained exclusively in the cytoplasm. It is suggested that kappaB-ras proteins preferentially bind to the IkappaB-beta form through this unique insert within the ankyrin region, thus modulating the cellular location of IkappaB-beta and regulating the rate of degradation of IkappaB-beta. This &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; is specific for kappaB-ras1 and has no cross-reactivity to kappaB-ras2.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;KappaB ras1, NF-kappaB inhibitor-interacting Ras like protein 1, kappaB-ras1, NKIRAS1&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C2493.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 165px; height: 150px;" src="http://www.biosyn.com/Images%5Cantibody%5C2493.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot analysis of KappaB ras1 in RAW264.7 cell lysate with KappaB ras1 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at (A) 0.5, (B) 1 and (C) 2 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunocytochemistry of KappaB-ras1 in RAW264.7 cells with KappaB-ras1 antibody at 1 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_356.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 165px; height: 128px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_356.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;KappaB ras1 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; was raised against a 15 amino acid peptide from near the carboxy terminus of human KappaB ras1.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification:&lt;/span&gt; Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone:&lt;/span&gt; This is a polyclonal antibody.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host:&lt;/span&gt; KappaB ras1 antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application: &lt;/span&gt;KappaB ras1 antibody can be used for detection of KappaB ras1 by Western blot at 0.5 – 1 µg/ml.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s): &lt;/span&gt;E, WB, ICC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer:&lt;/span&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat.No. 2493P - KappaB ras1 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; KappaB ras1 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. Cat&lt;/span&gt;. No. 1283 - RAW264.7 Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity:&lt;/span&gt; H, M&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number:&lt;/span&gt; 7008402&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; AAF34998&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; NF-kappaB inhibitor-interacting Ras-like protein&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   1.&lt;/span&gt; Fenwick C, Na SY, Voll RE, et al. A subclass of Ras proteins that regulate the degradation of IkappaB. Science 2000; 287:869-73.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2. &lt;/span&gt;Chen Y, Wu J and Ghosh G. KappaB-Ras binds to the unique insert within the ankyrin repeat domain if IkappaBbeta and regulates cytoplasmic retention of IkappaBbeta x NF-kappaB complexes. J. Biol. Chem. 2003; 278:23101-6.&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-4951290962823319322?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/4951290962823319322/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=4951290962823319322' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4951290962823319322'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4951290962823319322'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/kappab-ras1-antibody.html' title='KappaB ras1 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-219386644591881925</id><published>2011-08-22T09:54:00.004-08:00</published><updated>2011-08-22T09:57:50.252-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>KappaB ras Antibody</title><content type='html'>&lt;div  style="text-align: center;font-family:verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/KappaB_ras_Antibody-4361.aspx"&gt;&lt;span style="font-weight: bold;"&gt;KappaB ras Antibody&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;:2491&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;KappaB ras-1 (kappaB-ras-1) and kappaB-ras-2 are two small proteins that similar to Ras-like small GTPases that associate with IkappaB (IkappaB), an inhibitor of the transcription factor NF-kappaB. IkappaB exists in two homologous forms, IkappaB-alpha and IkappaB-beta, although IkappaB-beta contains a unique 47-amino acid region within its ankyrin domain. While inactive IkappaB-alpha-NF-kappaB complexes can shuttle in and out of the nucleus, IkappaB-beta-NF-kappaB complexes are retained exclusively in the cytoplasm. It is suggested that kappaB-ras proteins preferentially bind to the IkappaB-beta form through this unique insert within the ankyrin region, thus modulating the cellular location of IkappaB-beta and regulating the rate of degradation of IkappaB-beta. This &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; detects both kappaB-ras1 and kappaB-ras2.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong style="font-family: verdana;"&gt;Additional Names: &lt;/strong&gt;&lt;/span&gt;                            &lt;span style="font-size:100%;"&gt;&lt;span style="font-family:verdana;"&gt;KappaB ras, NF-kappaB inhibitor-interacting Ras like protein, kappaB-ras, NKIRAS&lt;/span&gt;&lt;br /&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C2491.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 175px; height: 178px;" src="http://www.biosyn.com/Images%5Cantibody%5C2491.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;                                         Left: Western blot analysis of  KappaB ras in 293 cell lysate with KappaB ras &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; at (A) 2 and (B) 4  µg/ml. Below: Immunohistochemistry of KappaB ras in human lymph node  tissue with KappaB ras antibody at 1 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;&lt;br /&gt;&lt;br /&gt;Source:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt;KappaB ras antibody was raised against a 18 amino acid &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; from near the center of human KappaB ras 1.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Purification: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;Affinity chromatography purified via peptide column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Clonality and Clone: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family:verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Host: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;KappaB ras antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Application: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;KappaB ras antibody can be used for detection of KappaB ras by Western blot at 2 – 4 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Tested Application(s): &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;E, WB, IHC&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Buffer:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt;Cat.No. 2491P - KappaB ras &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; KappaB ras antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;1. Cat. No. 1210 - 293 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;2. Cat. No. 1369 - Human Lymph Node Tissue Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Species Reactivity:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; H, M, R&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;GI Number:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; 7008402&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Accession Number: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;AAF34998&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Short Description:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; NF-kappaB inhibitor-interacting Ras-like protein&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;   1.&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; Fenwick C, Na SY, Voll RE, et al. A subclass of Ras proteins that regulate the degradation of IkappaB. Science 2000; 287:869-73.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;   2.&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; Chen Y, Wu J and Ghosh G. KappaB-Ras binds to the unique insert within the ankyrin repeat domain if IkappaBbeta and regulates cytoplasmic retention of IkappaBbeta x NF-kappaB complexes. J. Biol. Chem. 2003; 278:23101-6.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-219386644591881925?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/219386644591881925/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=219386644591881925' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/219386644591881925'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/219386644591881925'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/kappab-ras-antibody.html' title='KappaB ras Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-6203287129736601684</id><published>2011-08-22T09:50:00.003-08:00</published><updated>2011-08-22T09:53:45.512-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>KAI1 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/KAI1_Antibody-4470.aspx"&gt;&lt;span style="font-weight: bold;"&gt;KAI1 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:4073&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;KAI1 was initially identified from a T-cell activation study as a four-transmembrane protein that plays an accessory role in T-cell activation, and was later determined to act as a cancer metastasis suppressor gene. This protein is ubiquitously expressed at moderate to high levels in most tissues, but its expression is downregulated during tumor progression. The loss of KAI1 and p53 is associated with poor survival for prostate and other cancer patients. Recently, KAI1 was found to interact with DARC, the Duffy antigen for chemokines using a yeast two hybrid screen. It is thought that tumor cells dislodged from the primary tumor and expressing KAI1 interact with DARC proteins expressed on vascular cells, transmitting a senescent signal to the tumor cells, while tumor cells that have lost KAI1 expression can proliferate and potentially give rise to metastases. At least two isoforms of KAI1 are known to exist.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;KAI1 (CT), CD82 antigen, tetraspanin-27, Tspan-27, suppressor of tumorgenicity-6&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C4073.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 167px; height: 211px;" src="http://www.biosyn.com/Images%5Cantibody%5C4073.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot analysis of KAI1 in A549 cell lysate with KAI1 antibody at (A) 0.5 and (B) 1 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunohistochemistry of KAI1 in human colon tissue with KAI1 antibody at 2.5 μg/ml.                                                                                 &lt;br /&gt;&lt;br /&gt;&lt;b&gt;&lt;br /&gt;Other Product Images&lt;/b&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;/span&gt;                                        &lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5Cd_449.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 169px; height: 127px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_449.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;KAI1 antibody was raised against a 15 amino acid peptide from near the carboxy terminus of human KAI1.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Affinity chromatography purified via peptide column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;This is a polyclonal antibody.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; KAI1 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; KAI1 antibody can be used for detection of KAI1 by Western blot at 0.5 – 1 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s):&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; E, WB, IHC&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat.No. 4073P - KAI1 Peptide&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;KAI1 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. Cat. No.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; 1203 - A549 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;2. Cat. No&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;. 1320 - Human Colon Tissue Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; H, M, R&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; 4504813&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; NP_002222&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;(CT) a tumor metastasis suppressoer gene&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   1. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;HW Gaugitsch, Hofer E, Huber NE, et al. A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen SM23. Eur. J. Immunol. 1991; 21:377-83.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;2.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Gil ML, Vita N, Lebel-Binay S, et al. A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. Cloning and functional studies. J. Immunol. 1992; 2826-33.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Dong JT, Lamb PW, Rinker-Schaeffer CW, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995; 884-86.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   4. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Kauffman EC, Robinson VL, Stadler WM, et al. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J. Urol. 2003; 169:1122-33&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-6203287129736601684?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/6203287129736601684/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=6203287129736601684' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/6203287129736601684'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/6203287129736601684'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/kai1-antibody.html' title='KAI1 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-4249253655943121192</id><published>2011-08-17T09:31:00.001-08:00</published><updated>2011-08-17T09:36:06.936-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Amino Acid Analysis Protein'/><category scheme='http://www.blogger.com/atom/ns#' term='Essential Amino Acids'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>Amino Acid Analysis Protein</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/amino_acid_analysis_protein.aspx"&gt;&lt;span style="font-weight: bold;"&gt;  Amino Acid Analysis Protein     &lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;Biosyn&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; provides amino acids analysis service. Using ion exchange, post-column Ninhydrin detection, we provide precise determination of protein quantities, but also provide detailed information regarding the relative amino acid composition that gives a characteristic protein profile, which is often sufficient for identification of a protein. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;An Essential Amino Acid&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;An essential amino acid or indispensable amino acid is an amino acid that cannot be &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;synthesized&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; de novo by the organism and therefore must be supplied in the diet. Nine amino acids are generally regarded as essential for humans: phenylalanine, valine, threonine, tryptophan, isoleucine, methionine, histidine, leucine, and lysine. Arginine is required by infants and growing kids. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Essential Amino Acids &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Amino Acids are the chemical units or "building blocks" of the body that make up proteins. Protein substances make up the muscles, tendons, organs, glands, nails, and hair. Growth, repair and maintenance of all cells are dependent upon them.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Amino Acid&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;In chemistry, an amino acid is a molecule containing both amine and carboxyl functional groups. In biochemistry, this term refers to alpha-&lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;amino acids&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; with the general formula H2NCHRCOOH, where R is an organic substituent. In the alpha amino acids, the amino and carboxylate groups are attached to the same carbon, which is called the α–carbon. The various alpha amino acids differ in which side chain (R group) is attached to their alpha carbon.&lt;/span&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-4249253655943121192?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/4249253655943121192/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=4249253655943121192' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4249253655943121192'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4249253655943121192'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/amino-acid-analysis-protein.html' title='Amino Acid Analysis Protein'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-3790457038181521545</id><published>2011-08-17T09:27:00.003-08:00</published><updated>2011-08-17T09:31:04.502-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>JPH4 Antibody</title><content type='html'>&lt;div style="text-align: center;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/JPH4_Antibody-3996.aspx"&gt;&lt;span style="font-family: verdana; font-weight: bold;"&gt;JPH4 Antibody&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;span style="font-weight: bold;"&gt;:4923&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Junctional complexes between the plasma membrane (PM) and endoplasmic/sarcoplasmic reticulum (ER/SR) are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. Junctophilins (JPs) are important components of the junctional complexes. JPs are composed of a carboxy-terminal hydrophobic segment spanning the ER/SR membrane and a remaining cytoplasmic domain that shows specific affinity for the PM. Four JPs have been identified as tissue-specific subtypes derived from different genes: JPH1 is expressed in skeletal muscle, JPH2 is detected throughout all muscle cell types, and JPH3 and JPH4 are predominantly expressed in the brain. In the CNS, both JPH3 and JPH4 are expressed throughout neural sites and contribute to the subsurface cistern formation in neurons. Mice lacking both JPH3 and JPH4 subtypes exhibit serious symptoms such as impaired learning and memory and are accompanied by abnormal nervous functions.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;JPH4 (CT), Junctophilin 4, JPHL1, hJP-4&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C4923.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 169px; height: 314px;" src="http://www.biosyn.com/Images%5Cantibody%5C4923.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;                                                                                                                                                                                                     &lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot  analysis of JPH4 in 293 cell lysate with JPH4 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at 1 µg/ml in (A)  the absence and (B) the presence of blocking &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunohistochemistry of JPH4 in human brain tissue with JPH4 &lt;a href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at 2.5 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Other Product Images&lt;/b&gt;&lt;/span&gt;                                                                               &lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5Cd_900.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 169px; height: 138px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_900.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;JPH4 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; was raised against a 16 amino acid &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; near the carboxy terminus of human JPH4.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Affinity chromatography purified via peptide column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;This is a polyclonal antibody.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;JPH4 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;JPH4 antibody can be used for detection of JPH4 by Western blot at 1 – 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s): &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;E, WB, IHC&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat.No. 4923P - JPH4 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;JPH4 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. Cat. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;No. 1210 - 293 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;: H, M, R&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;33585440&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; AAH55429&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; (CT) T tubule, SR membrane, sarcoplasmic reticulum&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;  1. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Takeshima H, Komazaki S, Nishi M, et al. Junctophilins: a novel family of junctional membrane complex proteins. Mol. Cell. 2000; 6:11-22.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;  2.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Kakizawa S, Kishimoto Y, Hashimoto K, et al. Junctophilin-mediated channel crosstalk essential for cerebellar synaptic plasticity. EMBO J. 2007; 26:1924-33.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Nishi M, Sakagami H, Komazaki S, et al. Coexpression of junctophilin type 3 and type 4 in brain. Brain Res. Mol. Brain Res. 2003; 118:102-10.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;  4. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Moriguchi S, Nishi M, Komazaki S, et al. Functional uncoupling between Ca2+ release and afterhyperpolarization in mutant hippocampal neurons lacking junctophilins. Proc. Natl. Acad. Sci. 2006; 103:10811-6.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-3790457038181521545?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/3790457038181521545/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=3790457038181521545' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/3790457038181521545'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/3790457038181521545'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/jph4-antibody.html' title='JPH4 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-9179034911209134346</id><published>2011-08-17T09:23:00.005-08:00</published><updated>2011-08-17T09:26:54.301-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>JPH3 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/JPH3_Antibody-3995.aspx"&gt;&lt;span style="font-weight: bold;"&gt;JPH3 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:4921&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Junctional complexes between the plasma membrane (PM) and endoplasmic/sarcoplasmic reticulum (ER/SR) are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. Junctophilins (JPs) are important components of the junctional complexes. JPs are composed of a carboxy-terminal hydrophobic segment spanning the ER/SR membrane and a remaining cytoplasmic domain that shows specific affinity for the PM. Four JPs have been identified as tissue-specific subtypes derived from different genes: JPH1 is expressed in skeletal muscle, JPH2 is detected throughout all muscle cell types, and JPH3 and JPH4 are predominantly expressed in the brain. In the CNS, both JPH3 and JPH4 are expressed throughout neural sites and contribute to the subsurface cistern formation in neurons. Mice lacking both JPH3 and JPH4 subtypes exhibit serious symptoms such as impaired learning and memory and are accompanied by abnormal nervous functions. A repeat expansion in JPH3 is associated with Huntington disease-like 2. At least two isoforms of JPH3 are known to exist.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;JPH3 (CT), Junctophilin 3, JP3, JP-3, TNRC22, HDL2&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C4921.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 168px; height: 228px;" src="http://www.biosyn.com/Images%5Cantibody%5C4921.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                                                                                                                                                                                                                             &lt;span style="font-size:100%;"&gt; Western blot  analysis of JPH3 in Daudi cell lysate with JPH3 &lt;a style="font-weight: bold;" href="http://www.biosyn.com"&gt;antibody&lt;/a&gt; at 1 µg/ml in  (A) the absence and (B) the presence of blocking &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunohistochemistry of JPH3 in human brain tissue with JPH3 antibody at 2.5 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_899.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 168px; height: 134px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_899.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;JPH3 &lt;a style="font-weight: bold;" href="http://www.biosyn.com"&gt;antibody&lt;/a&gt; was raised against a 18 amino acid &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; near the carboxy terminus of human JPH3.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification: &lt;/span&gt;Affinity chromatography purified via peptide column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone: &lt;/span&gt;This is a polyclonal antibody.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host:&lt;/span&gt; JPH3 &lt;a style="font-weight: bold;" href="http://www.biosyn.com"&gt;antibody&lt;/a&gt; was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; JPH3 antibody can be used for detection of JPH3 by Western blot at 1 – 2 µg/ml.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s):&lt;/span&gt; E, WB, IHC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer:&lt;/span&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat.No. 4921P - JPH3 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; JPH3 &lt;a style="font-weight: bold;" href="http://www.biosyn.com"&gt;antibody&lt;/a&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. Cat. No. &lt;/span&gt;1224 - Daudi Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity:&lt;/span&gt; H, M, R&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number: &lt;/span&gt;21704283&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; NP_065706&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description: &lt;/span&gt;(CT) T tubule, SR membrane, sarcoplasmic reticulum&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;  &lt;span style="font-weight: bold;"&gt; 1. &lt;/span&gt;Takeshima H, Komazaki S, Nishi M, et al. Junctophilins: a novel family of junctional membrane complex proteins. Mol. Cell. 2000; 6:11-22.&lt;br /&gt; &lt;span style="font-weight: bold;"&gt;  2.&lt;/span&gt; Kakizawa S, Kishimoto Y, Hashimoto K, et al. Junctophilin-mediated channel crosstalk essential for cerebellar synaptic plasticity. EMBO J. 2007; 26:1924-33.&lt;br /&gt;   &lt;span style="font-weight: bold;"&gt;3. &lt;/span&gt;Nishi M, Sakagami H, Komazaki S, et al. Coexpression of junctophilin type 3 and type 4 in brain. Brain Res. Mol. Brain Res. 2003; 118:102-10.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   4. &lt;/span&gt;Moriguchi S, Nishi M, Komazaki S, et al. Functional uncoupling between Ca2+ release and afterhyperpolarization in mutant hippocampal neurons lacking junctophilins. Proc. Natl. Acad. Sci. 2006; 103:10811&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-9179034911209134346?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/9179034911209134346/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=9179034911209134346' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/9179034911209134346'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/9179034911209134346'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/jph3-antibody_17.html' title='JPH3 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-5855010184648353820</id><published>2011-08-17T09:15:00.003-08:00</published><updated>2011-08-17T09:22:54.034-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>JPH3 Antibody</title><content type='html'>&lt;div  style="text-align: center;font-family:verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/JPH3_Antibody-3998.aspx"&gt;&lt;span style="font-weight: bold;"&gt;JPH3 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;:4931&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Junctional complexes between the plasma membrane (PM) and endoplasmic/sarcoplasmic reticulum (ER/SR) are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. Junctophilins (JPs) are important components of the junctional complexes. JPs are composed of a carboxy-terminal hydrophobic segment spanning the ER/SR membrane and a remaining cytoplasmic domain that shows specific affinity for the PM. Four JPs have been identified as tissue-specific subtypes derived from different genes: JPH1 is expressed in skeletal muscle, JPH2 is detected throughout all muscle cell types, and JPH3 and JPH4 are predominantly expressed in the brain. In the CNS, both JPH3 and JPH4 are expressed throughout neural sites and contribute to the subsurface cistern formation in neurons. Mice lacking both JPH3 and JPH4 subtypes exhibit serious symptoms such as impaired learning and memory and are accompanied by abnormal nervous functions. A repeat expansion in JPH3 is associated with Huntington disease-like 2. At least two isoforms of JPH3 are known to exist.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div  class="npdet_box2" style="font-family:verdana;"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;JPH3 (IN), Junctophilin 3, JP3, JP-3, TNRC22, HDL2&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C4931.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 168px; height: 314px;" src="http://www.biosyn.com/Images%5Cantibody%5C4931.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot  analysis of JPH3 in Daudi cell lysate with JPH3 antibody at 1 µg/ml in  (A) the absence and (B) the presence of blocking peptide.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunohistochemistry of JPH3 in human brain tissue with JPH3 antibody at 2.5 µg/ml.                                                                               &lt;br /&gt;&lt;br /&gt;&lt;b&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Other Product Images&lt;br /&gt;&lt;br /&gt;&lt;/b&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_902.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 169px; height: 140px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_902.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:J&lt;/span&gt;PH3 antibody was raised against a 18 amino acid peptide near the center of human JPH3.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification:&lt;/span&gt; Affinity chromatography purified via peptide column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone: &lt;/span&gt;This is a polyclonal antibody.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host:&lt;/span&gt; JPH3 antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; JPH3 antibody can be used for detection of JPH3 by Western blot at 1 – 2 µg/ml.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s):&lt;/span&gt; E, WB, IHC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat.No. 4931P - JPH3 Peptide&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage: &lt;/span&gt;JPH3 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. &lt;/span&gt;Cat. No. 1224 - Daudi Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity:&lt;/span&gt; H, M, R&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number:&lt;/span&gt; 21704283&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; NP_065706&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; (IN) T tubule, SR membrane, sarcoplasmic reticulum&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   1. &lt;/span&gt;Takeshima H, Komazaki S, Nishi M, et al. Junctophilins: a novel family of junctional membrane complex proteins. Mol. Cell. 2000; 6:11-22.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2&lt;/span&gt;. Kakizawa S, Kishimoto Y, Hashimoto K, et al. Junctophilin-mediated channel crosstalk essential for cerebellar synaptic plasticity. EMBO J. 2007; 26:1924-33.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   3.&lt;/span&gt; Nishi M, Sakagami H, Komazaki S, et al. Coexpression of junctophilin type 3 and type 4 in brain. Brain Res. Mol. Brain Res. 2003; 118:102-10.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   4. &lt;/span&gt;Moriguchi S, Nishi M, Komazaki S, et al. Functional uncoupling between Ca2+ release and afterhyperpolarization in mutant hippocampal neurons lacking junctophilins. Proc. Natl. Acad. Sci. 2006; 103:10811-6.&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-5855010184648353820?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/5855010184648353820/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=5855010184648353820' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5855010184648353820'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5855010184648353820'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/jph3-antibody.html' title='JPH3 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-984352842709764892</id><published>2011-08-09T07:58:00.000-08:00</published><updated>2011-08-09T08:01:48.294-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>Acyl Carrier Protein (ACP) Fragments Products</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Peptides/Acyl_Carrier_Protein_%28ACP%29_Fragments/Products.aspx"&gt;&lt;span style="font-weight: bold;"&gt;Acyl Carrier Protein (ACP) Fragments Products&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Definition&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Acyl Carrier Protein (ACP) is a component of plastid-located plant &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;fatty acid synthetase&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;. It binds acyl groups covalently via the prosthetic group, 4-phosphopantetheine, during the biosynthesis of fatty acids.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Discovery&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Hansen L in 1987 identified three isoforms of ACP in barley leaves. Protein sequence data have been obtained for ACP I and II, and in addition genomic clones encoding ACP I and III have been characterized . A scheme has been devised for the preparation of semisynthetic derivatives of acyl carrier protein (ACP). Acetylated synthetic ACP is coupled via its activated pentachlorophenol ester to native ACP, which had previously been acetylated and converted to the S-5′-dithiobis(2-nitrobenzoate)(DTNB) derivative. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Structural Characteristics&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Residue 1-74 of ACP, a 77-residue single-chain protein of E.coli with a 4'-hosphopantetheine prosthetic group, is a suitable, simple model to study the chemical &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;synthesis&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; of small proteins. The sequence of Acyl Carrier Protein (ACP) (65-74) (acid) is H-Val-Gln-Ala-Ala-Ile-Asp-Tyr-Ile-Asn-Gly-OH.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The solution structure of B. subtilis ACP (9 kDa) has been determined using two-dimensional and three-dimensional heteronuclear NMR spectroscopy. The overall ACP structure consists of a four α-helical bundle in which 4-PP is attached to the conserved Ser36 that is located in α helix II. Structural data suggest that the two forms of ACP are essentially identical. The structural difference between B. subtilis ACP and both E. coli and act apo-ACP is not attributed to an inherent difference in the proteins, but is probably a result of a limitation in the methodology available for the analysis for E. coli and act apo-ACP. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Mode of Action&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Acyl carrier protein (ACP) is a fundamental component of fatty acid biosynthesis in which the fatty acid chain is elongated by the fatty acid synthetase system while attached to the 4-phosphopantetheine prosthetic group (4-PP) of ACP. Activation of ACP is mediated by holo-acyl carrier protein synthase (ACPS) when ACPS transfers the 4-PP moiety from coenzyme A (CoA) to Ser36 of apo-ACP. Both ACP and ACPS have been identified as essential for E. coli viability and potential targets for development of&lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt; antibiotic &lt;/a&gt;&lt;span style="font-family: verdana;"&gt;. Circular dichroism of recombinant Vibrio harveyi ACP and mutant derivatives of conserved residues Phe-50, Ile-54, Ala-59, and Tyr-71 revealed that, unlike Escherichia coli ACP, V. harveyi-derived ACPs are unfolded at neutral pH in the absence of divalent cations; all except F50A and I54A recovered native conformation upon addition of MgCl2. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Functions&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;Synthesis of fatty acid&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; sand phospholipids, acyl carrier protein (ACP) interacts with many different enzymes during the synthesis of fatty acids, phospholipids, and other specialized products in bacteria .&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;ACP structure and conformation, fatty acid attachment stabilizes mutant ACPs in a chain length-dependent manner, although stabilization was decreased for mutants F50A and A59G. Results indicate that (i) residues Ile-54 and Phe-50 are important in maintaining native ACP conformation, (ii) residue Ala-59 may be directly involved in stabilization of ACP structure by acyl chain binding.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;Synthesis&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; of membrane-derived oligosaccharides, the function of ACP in the synthesis of membrane-derived oligosaccharides is thus clearly different from that involved in lipid biosynthesis. The same molecular species of ACP that undergo enzymic acylation with long-chain fatty acid residues also function in the synthesis of membrane-derived oligosaccharides .&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1.  &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;   Hansen L (1987). Three cDNA clones for barley leaf acyl carrier proteins I and III. Carlsberg Res Commun., 52:381-392.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;2.  &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;    Hoj PB, Svendsen IB (1984). Barley chloroplasts contain two acyl carrier proteins coded for by different genes. Carlsberg Res Commun., 49:483-492&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;3.  &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;   Suo Z, Tseng CC, Walsh CT (2001). Purification, priming, and catalytic acylation of carrier protein domains in the polyketide synthase and nonribosomal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;peptidyl synthetase&lt;/a&gt; modules of the HMWP1 subunit of yersiniabactin synthetase. PNAS., 98(1):99-104.&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;4.  &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;   Flaman AS, Chen JM, Van Iderstine SC, Byers DM (2001). Site-directed mutagenesis of acyl carrier protein (ACP) reveals amino acid residues involved in acp structure and acyl-acp synthetase activity J Biol Chem., 276(38):35934-35939.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;5.   &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;  Therisod H, Kennedy EP (1987). The function of acyl carrier protein in the synthesis of membrane-derived oligosaccharides does not require its phosphopantetheine prosthetic group. PNAS., 84(23):8235–8238. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-984352842709764892?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/984352842709764892/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=984352842709764892' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/984352842709764892'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/984352842709764892'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/acyl-carrier-protein-acp-fragments.html' title='Acyl Carrier Protein (ACP) Fragments Products'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-3184575311224907212</id><published>2011-08-08T08:11:00.000-08:00</published><updated>2011-08-08T08:12:59.994-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Family Tree DNA DNA and Labeling Techniques'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>DNA Testing Lab</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/dna_testing_lab.aspx"&gt;&lt;span style="font-weight: bold;"&gt;DNA Testing Lab &lt;/span&gt;     &lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;Bio-Synthesis&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;, an international provider of DNA testing services including: government agencies, private institutions, or individuals who need &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;DNA testing&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; for various reasons. We offer comprehensive services such as paternity, maternity and other kinship identification. Our facilities are operated under AABB accreditation guidelines for all your private or legal DNA tests.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Family Tree DNA&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;This DNA testing service includes a surname-based reconstruction program to help you connect with relatives when the conventional paper trail ends. Probably the most popular genealogy DNA testing service, with one of the largest DNA databases as well.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Genetic Fingerprinting&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Genetic fingerprinting (also called &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;DNA testing&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;, DNA typing, or DNA profiling) is a technique used to distinguish between individuals of the same species using only samples of their DNA. Although two individuals will have the vast majority of their DNA sequence in common, DNA profiling exploits highly variable repeat sequences called VNTRs.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;DNA and Labeling Techniques&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;A variety of probes can be used for in situ hybridization, depending on the application and the labeling strategy. In general, &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;RNA probes&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; (riboprobes) are now more commonly used. However, some laboratories may still prefer to use DNA probes for in situ hybridization.&lt;/span&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-3184575311224907212?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/3184575311224907212/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=3184575311224907212' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/3184575311224907212'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/3184575311224907212'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/dna-testing-lab.html' title='DNA Testing Lab'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-5820471827122907138</id><published>2011-08-08T07:55:00.004-08:00</published><updated>2011-08-08T07:59:40.204-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>JPH2 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/JPH2_Antibody-3997.aspx"&gt;&lt;span style="font-weight: bold;"&gt;JPH2 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;#:4929&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Junctional complexes between the plasma membrane (PM) and endoplasmic/sarcoplasmic reticulum (ER/SR) are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. Junctophilins (JPs) are important components of the junctional complexes. JPs are composed of a carboxy-terminal hydrophobic segment spanning the ER/SR membrane and a remaining cytoplasmic domain that shows specific affinity for the PM. Four JPs have been identified as tissue-specific subtypes derived from different genes: JPH1 is expressed in skeletal muscle, JPH2 is detected throughout all muscle cell types, and JPH3 and JPH4 are predominantly expressed in the brain and contribute to the subsurface cistern formation in neurons. JPH2-null mice died of embryonic cardiac arrest and human patients with mutations in the JPH2 gene showed hypertrophic cardiomyopathy, demonstrating the importance of this protein. Multiple isoforms of JPH2 are known to exist.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong style="font-family: verdana;"&gt;Additional Names: &lt;/strong&gt;&lt;/span&gt;                           &lt;span style="font-size:100%;"&gt;&lt;span style="font-family: verdana;"&gt;JPH2 (CT2), Junctophilin 2, JP2, JP-2&lt;/span&gt;&lt;br /&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C4929.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 169px; height: 252px;" src="http://www.biosyn.com/Images%5Cantibody%5C4929.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of JPH2 in mouse brain tissue lysate with JPH2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at (A) 1 and (B) 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Below:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Immunohistochemistry of JPH2 in mouse skeletal muscle tissue with JPH2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at 2.5 µg/ml.                                                                                 &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;Other Product Images&lt;/b&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5Cd_901.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 169px; height: 129px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_901.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;JPH2 antibody was raised against a 17 amino acid &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; near the carboxy terminus of human JPH2.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Affinity chromatography purified via &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;JPH2 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;JPH2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for detection of JPH2 by Western blot at 1 – 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s): &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;E, WB, IHC&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat.No. 4929P - JPH2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; JPH2 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1.Cat. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;No. 1403 - Mouse Brain Tissue Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;H, M, R&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;21704281&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; NP_065166&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; (CT2) T tubule, SR membrane, sarcoplasmic reticulum&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   1.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Takeshima H, Komazaki S, Nishi M, et al. Junctophilins: a novel family of junctional membrane complex proteins. Mol. Cell. 2000; 6:11-22.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   2.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Kakizawa S, Kishimoto Y, Hashimoto K, et al. Junctophilin-mediated channel crosstalk essential for cerebellar synaptic plasticity. EMBO J. 2007; 26:1924-33.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Nishi M, Sakagami H, Komazaki S, et al. Coexpression of junctophilin type 3 and type 4 in brain. Brain Res. Mol. Brain Res. 2003; 118:102-10.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   4.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Matsushita Y, Furukawa T, Kasanuki H, et al. Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy. J. Hum. Genet. 2007; 52:543-8.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;                                        &lt;div style="font-family: verdana;" class="npdet_box2"&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-5820471827122907138?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/5820471827122907138/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=5820471827122907138' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5820471827122907138'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5820471827122907138'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/jph2-antibody_08.html' title='JPH2 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-7346451626492366306</id><published>2011-08-08T07:52:00.004-08:00</published><updated>2011-08-08T07:55:21.822-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>JPH2 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/JPH2_Antibody-4011.aspx"&gt;&lt;span style="font-weight: bold;"&gt;JPH2 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:4919&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Junctional complexes between the plasma membrane (PM) and endoplasmic/sarcoplasmic reticulum (ER/SR) are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. Junctophilins (JPs) are important components of the junctional complexes. JPs are composed of a carboxy-terminal hydrophobic segment spanning the ER/SR membrane and a remaining cytoplasmic domain that shows specific affinity for the PM. Four JPs have been identified as tissue-specific subtypes derived from different genes: JPH1 is expressed in skeletal muscle, JPH2 is detected throughout all muscle cell types, and JPH3 and JPH4 are predominantly expressed in the brain and contribute to the subsurface cistern formation in neurons. JPH2-null mice died of embryonic cardiac arrest and human patients with mutations in the JPH2 gene showed hypertrophic cardiomyopathy, demonstrating the importance of this protein. Multiple isoforms of JPH2 are known to exist.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;JPH2 (CT), Junctophilin 2, JP2, JP-2&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C4919.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 168px; height: 307px;" src="http://www.biosyn.com/Images%5Cantibody%5C4919.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Western blot  analysis of JPH2 in 293 cell lysate with JPH2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at 2 µg/ml in (A)  the absence and (B) the presence of blocking &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;JPH2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a 14 amino acid &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; near the carboxy terminus of human JPH2.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Affinity chromatography purified via peptide column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; JPH2 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; JPH2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for detection of JPH2 by Western blot at 1 – 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Tested Application(s): E, WB&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat.No. 4919P - JPH2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; JPH2 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1.Cat. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;No. 1210 - 293 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;H, M, R&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; 21704281&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; NP_065166&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description: (&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;CT) T tubule, SR membrane, sarcoplasmic reticulum&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   1. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Takeshima H, Komazaki S, Nishi M, et al. Junctophilins: a novel family of junctional membrane complex proteins. Mol. Cell. 2000; 6:11-22.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   2.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Kakizawa S, Kishimoto Y, Hashimoto K, et al. Junctophilin-mediated channel crosstalk essential for cerebellar synaptic plasticity. EMBO J. 2007; 26:1924-33.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Nishi M, Sakagami H, Komazaki S, et al. Coexpression of junctophilin type 3 and type 4 in brain. Brain Res. Mol. Brain Res. 2003; 118:102-10.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   4. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Matsushita Y, Furukawa T, Kasanuki H, et al. Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy. J. Hum. Genet. 2007; 52:543-8.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;                                         &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-7346451626492366306?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/7346451626492366306/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=7346451626492366306' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7346451626492366306'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7346451626492366306'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/jph2-antibody.html' title='JPH2 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-302387440063616625</id><published>2011-08-08T07:46:00.005-08:00</published><updated>2011-08-08T07:51:45.162-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>JPH1 Antibody</title><content type='html'>&lt;div  style="text-align: center;font-family:verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/JPH1_Antibody-4010.aspx"&gt;&lt;span style="font-weight: bold;"&gt;JPH1 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;:4917&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Junctional complexes between the plasma membrane (PM) and endoplasmic/sarcoplasmic reticulum (ER/SR) are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. Junctophilins (JPs) are important components of the junctional complexes. JPs are composed of a carboxy-terminal hydrophobic segment spanning the ER/SR membrane and a remaining cytoplasmic domain that shows specific affinity for the PM. Four JPs have been identified as tissue-specific subtypes derived from different genes: JPH1 is expressed in skeletal muscle, JPH2 is detected throughout all muscle cell types, and JPH3 and JPH4 are predominantly expressed in the brain and contribute to the subsurface cistern formation in neurons. JPH1 is essential for stabilizing the T-tubule and SR membranes to form junctions and provide an environment for the assembly of receptors such as the ryanodine receptor type 1 (RyR1).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong style="font-family: verdana;"&gt;Additional Names: &lt;/strong&gt;&lt;/span&gt;                           &lt;span style="font-size:100%;"&gt;&lt;span style="font-family:verdana;"&gt;JPH1, Junctophilin 1, JP1, JP-1&lt;/span&gt;&lt;br /&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C4917.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 168px; height: 313px;" src="http://www.biosyn.com/Images%5Cantibody%5C4917.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt;&lt;span style="font-family:verdana;"&gt; Western blot analysis of JPH1 in 293 cell lysate with JPH1 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; at (A) 1 and (B) 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Below:&lt;/b&gt;&lt;span style="font-family:verdana;"&gt; Immunohistochemistry of JPH1 in mouse skeletal muscle tissue with JPH1 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; at 2.5 µg/ml.                                                                                 &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5Cd_898.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 168px; height: 136px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_898.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Source:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt;JPH1 antibody was raised against a 15 amino acid &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; near the carboxy terminus of human JPH1.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Purification:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; Affinity chromatography purified via &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family:verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Host: JPH1 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Application: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;JPH1 antibody can be used for detection of JPH1 by Western blot at 1 – 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Tested Application(s)&lt;/span&gt;&lt;span style="font-family:verdana;"&gt;: E, WB, IHC&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Buffer: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt;Cat.No. 4917P - JPH1 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; JPH1 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;1. Cat. No. 1210 - 293 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Species Reactivity&lt;/span&gt;&lt;span style="font-family:verdana;"&gt;: H, M, R&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;GI Number: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;145337941&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Accession Number:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; AAI39833&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Short Description:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; T tubule, SR membrane, sarcoplasmic reticulum&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;   1. &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;Takeshima H, Komazaki S, Nishi M, et al. Junctophilins: a novel family of junctional membrane complex proteins. Mol. Cell. 2000; 6:11-22.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;   2.&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; Kakizawa S, Kishimoto Y, Hashimoto K, et al. Junctophilin-mediated channel crosstalk essential for cerebellar synaptic plasticity. EMBO J. 2007; 26:1924-33.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;  &lt;/span&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt; 3. &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;Nishi M, Sakagami H, Komazaki S, et al. Coexpression of junctophilin type 3 and type 4 in brain. Brain Res. Mol. Brain Res. 2003; 118:102-10.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;   4.&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; Phimister AJ, Lango J, Lee EH, et al. Conformation-dependent stability of Junctophilin 1 (JP1) and Ryanodine Receptor type 1 (RyR1) channel complex is mediated by their hyper-reactive thiols. J. Biol. Chem. 2007; 282:8867-77.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-302387440063616625?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/302387440063616625/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=302387440063616625' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/302387440063616625'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/302387440063616625'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/jph1-antibody.html' title='JPH1 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-8023837363425016828</id><published>2011-08-01T07:55:00.001-08:00</published><updated>2011-08-01T08:20:07.263-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='DNA Nanotechnology'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Adoption DNA Testing'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Labeling of Duplex DNA'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>Labeling of Duplex DNA</title><content type='html'>&lt;div style="text-align: center; font-weight: bold; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/labeling_of_duplex_dna.aspx"&gt;Labeling of Duplex DNA&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;BIO-SYNTHESIS&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; is second to none in its ability to meet our customer's needs, often providing modified DNA with wide variety of selections. BSI offer duplex DNA synthesis and labeling at competitive prices and quick delivery. Bio-Synthesis continued to provide quality DNA products and services for the research community, Visit &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;www.biosyn.com&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; and see why partner with Bio-Synthesis for your custom duplex DNA needs.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;DNA Nanotechnology &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;DNA nanotechnology uses the unique molecular recognition properties of DNA and other nucleic acids to create self-assembling branched &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;DNA complexes&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; with useful properties. DNA is thus used as a structural material rather than as a carrier of biological information.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;DNA Repair&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;DNA repair refers to a collection of processes by which a cell identifies and corrects damage to the DNA molecules that encode its genome. In human cells, both normal metabolic activities and environmental factors such as UV light and Radiation can cause DNA damage, resulting in as many as 1 million individual molecular lesions per cell per day.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Adoption DNA Testing&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;It offers&lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt; DNA testing services&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; for people involved in adoption. We have specialized services for clients who are going through domestic or international adoptions, are hoping for reunification with biological family members, or are facilitating parental relinquishment and peace of mind.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;For more information visit: &lt;/span&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com"&gt;&lt;span style="font-weight: bold;"&gt;www.biosyn.com&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-8023837363425016828?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/8023837363425016828/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=8023837363425016828' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/8023837363425016828'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/8023837363425016828'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/labeling-of-duplex-dna.html' title='Labeling of Duplex DNA'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-2847282431266989500</id><published>2011-08-01T07:50:00.004-08:00</published><updated>2011-08-01T07:55:31.618-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IRS-1 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRS-1_Antibody-4133.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IRS-1 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;#:3521&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Following tyrosine phosphorylation, the insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) can form a protein scaffolding for the assembly of a host of Src homology 2 (SH2) domain-containing proteins (1). IRS-1 tyrosine phosphorylation can occur through the activity of several cytokine and growth factor receptors such as interleukin (IL)-4, IL-9, interferon-?, in addition to the insulin and insulin-like growth factor 1 receptors (2). The scaffolding provided by IRS-1 and IRS-2 is necessary for insulin signal transduction across the cell membrane. IRS-1 tyrosine phosphorylation, and thus formation of the IRS scaffolding is inhibited by tumor necrosis factor (TNF), and this inhibition can itself be blocked by rapamycin, an inhibitor of the mammalian target of rapamycin (TOR) (3,4). TNF activity could also be blocked by inhibition of the Akt kinase and the PTEN tumor suppressor, suggesting that TNF impairs insulin signaling through IRS-1 by activation of the TOR signaling pathway (3).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IRS-1, Insulin receptor substrate-1&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C3521.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 128px; height: 175px;" src="http://www.biosyn.com/Images%5Cantibody%5C3521.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot analysis of IRS-1 in PC-3 cell lysate with IRS-1 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at (A) 1, (B) 2 and (C) 4 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunocytochemistry of IRS-1 in P815 cells with IRS-1 antibody at 2 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Image&lt;br /&gt;&lt;/b&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_190.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 226px; height: 240px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_190.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IRS-1 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; was raised against a 16 amino acid &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; from near the center of human IRS-1.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification: &lt;/span&gt;Affinity chromatography purified via peptide column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone:&lt;/span&gt; This is a polyclonal &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host: &lt;/span&gt;IRS-1 antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Immunogen:&lt;/span&gt; Human IRS-1 / Insulin receptor substrate-1 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt; (Cat. No. 3521P)&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; IRS-1antibody can be used for the detection of IRS-1 by Western blot at 1 - 2 µg/ml.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s): &lt;/span&gt;E, WB, ICC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat. No. 3521P - IRS-1 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage: &lt;/span&gt;IRS-1 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. Cat.&lt;/span&gt; No. 1216 - PC-3 Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;2. Cat. &lt;/span&gt;No. 1286 - P815 Cell Lysate&lt;br /&gt;Species Reactivity: H, M&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number: &lt;/span&gt;547738&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; P35568&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; A scaffolding protein important for insulin receptor signaling&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;  &lt;span style="font-weight: bold;"&gt; 1. &lt;/span&gt;Giovannone B, Scaldaferri ML, Federici M, et al. Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential. Diabetes Metab. Res. Rev. 2000; 16:434-41.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2.&lt;/span&gt; Waters SB and Pessin JE. Insulin receptor substrate 1 and 2 (IRS1 and IRS2): what a tangled web we weave. Trends in Cell Biol. 1996; 6:1-4.&lt;br /&gt; &lt;span style="font-weight: bold;"&gt;  3.&lt;/span&gt; Ozes ON, Akca H, Mayo LD, et al. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl. Acad. Sci. USA 2001; 98:4640-5.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   4.&lt;/span&gt; Shamji AF, Ngheim P, and Schreiber SL. Integration of growth factor and nutrient signaling: implications for cancer biology. Mol. Cell 2003; 12:271-80.&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-2847282431266989500?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/2847282431266989500/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=2847282431266989500' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/2847282431266989500'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/2847282431266989500'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/irs-1-antibody.html' title='IRS-1 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-7984787967324920023</id><published>2011-08-01T07:44:00.002-08:00</published><updated>2011-08-01T07:50:02.542-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IRE1p Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRE1p_Antibody-4185.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IRE1p Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:3659&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Accumulation of malfolded proteins in the endoplasmic reticulum (ER) activates the unfolded protein response (UPR) and the upregulation of the ER molecular chaperones GRP78 and GRP 94 (1,2). These proteins are normally bound to ER transmembrane proteins such as IRE1p and ATF6 (3,4) but ER stress causes their dissociation. This allows IRE1p, a serine-threonine protein kinase to transduce the unfolded protein signal from the ER to the nucleus. IRE1p also has an endoribonuclease activity that is required to splice X-box binding protein (XBP1) mRNA converting it to a potent UPR transcriptional activation (5). Depletion of IRE1p through the expression of a dominant negative form of IRE1p has no effect on transfected cells, but cell death via apoptosis occurs under stress conditions that cause unfolded proteins to accumulate in the ER (6). Two alternatively spliced transcript variants encoding different isoforms have been found for this gene.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;strong&gt;Additional Names: &lt;/strong&gt;IRE1p (IN), Endoplasmic reticulum-to-nucleus signaling 1, ERN1&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C3659.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 117px; height: 181px;" src="http://www.biosyn.com/Images%5Cantibody%5C3659.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;                                        &lt;b&gt;Left:&lt;/b&gt; Western blot analysis of IRE1p in Raji cell lysate with IRE1p &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at (A) 1 and (B) 2 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IRE1p &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; was raised against a 15 amino acid &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; from near the center of human IRE1p.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification:&lt;/span&gt; Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone:&lt;/span&gt; This is a polyclonal antibody.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host:&lt;/span&gt; IRE1p antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Immunogen:&lt;/span&gt; Human IRE1p (Intermediate Domain) &lt;a href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt; (Cat. No. 3659P)&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application: &lt;/span&gt;IRE1p &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be used for the detection of IRE1p by Western blot at 1 – 2 µg/ml.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s):&lt;/span&gt; E, WB&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat. No. 3659P - IRE1p &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; IRE1p antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. Cat.&lt;/span&gt; No. 1207 - Raji Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity:&lt;/span&gt; H&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number: &lt;/span&gt;193806335&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; O75460&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; (IN) Endoplasmic reticulum-to-nucleus signaling 1&lt;br /&gt;References&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   1.&lt;/span&gt; Little E, Ramakrishnan M, Roy B, et al. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit. Rev. Eukaryot. Gene Expr. 1994; 4:1-18.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2. &lt;/span&gt;Lee AS. The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 2005; 35:373-81.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   3. &lt;/span&gt;Bertolotti A, Zhang Y, Hendershot LM, et al. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2000; 2:326-32.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   4. &lt;/span&gt;Shen J, Chen X, Hendershot L, et al. ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev. Cell 2002; 3:99-111.&lt;br /&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-7984787967324920023?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/7984787967324920023/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=7984787967324920023' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7984787967324920023'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7984787967324920023'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/ire1p-antibody_01.html' title='IRE1p Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-4364481325315270897</id><published>2011-08-01T07:33:00.006-08:00</published><updated>2011-08-01T07:44:27.232-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IRE1p Antibody</title><content type='html'>&lt;div  style="text-align: center;font-family:verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRE1p_Antibody-4184.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IRE1p Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;:3657&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Accumulation of malfolded proteins in the endoplasmic reticulum (ER) activates the unfolded protein response (UPR) and the upregulation of the ER molecular chaperones GRP78 and GRP 94 (1,2). These proteins are normally bound to ER transmembrane proteins such as IRE1p and ATF6 (3,4) but ER stress causes their dissociation. This allows IRE1p, a serine-threonine protein kinase to transduce the unfolded protein signal from the ER to the nucleus. IRE1p also has an endoribonuclease activity that is required to splice X-box binding protein (XBP1) mRNA converting it to a potent UPR transcriptional activation (5). Depletion of IRE1p through the expression of a dominant negative form of IRE1p has no effect on transfected cells, but cell death via apoptosis occurs under stress conditions that cause unfolded proteins to accumulate in the ER (6). Two alternatively spliced transcript variants encoding different isoforms have been found for this gene.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="npdet_box2"  style="font-family:verdana;"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IRE1p (NT), Endoplasmic reticulum-to-nucleus signaling 1, ERN1&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C3657.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 130px; height: 191px;" src="http://www.biosyn.com/Images%5Cantibody%5C3657.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt;&lt;span style="font-family:verdana;"&gt; Western blot analysis of IRE1p in A-20 cell lysate with IRE1p &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; at (A) 0.5, (B) 1 and (C) 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Below:&lt;/b&gt;&lt;span style="font-family:verdana;"&gt; Immunocytochemistry of IRE1p in A20 cells with IRE1p &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at 1 µg/ml.                                                                               &lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;Other Product Images&lt;br /&gt;&lt;br /&gt;&lt;/b&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5Cd_484.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 162px; height: 176px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_484.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Source:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt;IRE1p &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; was raised against a 15 amino acid &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; from near the amino terminus of human IRE1p.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Purification: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;Affinity chromatography purified via &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Clonality and Clone: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family:verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Host: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;IRE1p antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Immunogen: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;Human IRE1p (N-Terminus) Peptide (Cat. No. 3657P)&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Application:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; IRE1p antibody can be used for the detection of IRE1p by Western blot at 1 – 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Tested Application(s): &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;E, WB, ICC&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Buffer: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt;Cat. No. 3657P - IRE1p &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; IRE1p &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;1. Cat.&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; No. 1288 - A-20 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Species Reactivity&lt;/span&gt;&lt;span style="font-family:verdana;"&gt;: H, M, R&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;GI Number:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; 193806335&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Accession Number: &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;O75460&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Short Description:&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; (NT) Endoplasmic reticulum-to-nucleus signaling 1&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;   &lt;/span&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;1. &lt;/span&gt;&lt;span style="font-family:verdana;"&gt;Little E, Ramakrishnan M, Roy B, et al. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit. Rev. Eukaryot. Gene Expr. 1994; 4:1-18.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt; &lt;/span&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;  2.&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; Lee AS. The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 2005; 35:373-81.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;   3&lt;/span&gt;&lt;span style="font-family:verdana;"&gt;. Bertolotti A, Zhang Y, Hendershot LM, et al. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2000; 2:326-32.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;   4.&lt;/span&gt;&lt;span style="font-family:verdana;"&gt; Shen J, Chen X, Hendershot L, et al. ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev. Cell 2002; 3:99-111.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-4364481325315270897?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/4364481325315270897/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=4364481325315270897' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4364481325315270897'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4364481325315270897'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/08/ire1p-antibody.html' title='IRE1p Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-3375096490704458286</id><published>2011-07-28T07:11:00.000-08:00</published><updated>2011-07-28T07:17:17.804-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>ACV and Related Compounds Products</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Peptides/ACV_and_Related_Compounds/Products.aspx"&gt;&lt;span style="font-weight: bold;"&gt;ACV and Related Compounds Products&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Definition&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Acyclovir (ACV) is the key intermediate in the &lt;a style="font-weight: bold;" href="http://www.biosyn.com"&gt;biosynthesis&lt;/a&gt; of all penicillins and cephalosporins by eukaryotic and prokaryotic microorganisms.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Discovery&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Gnann J W et al., in 1983 studied the mechanism of action, pharmacokinetics and clinical applications of ACV . Tadepalli S et al., in 1986 developed a simple and sensitive enzyme-linked immunosorbent assay for the detection and quantitation of ACV in human plasma and urine. ACV immobilized on a solid phase and free acyclovir in the sample solution were allowed to compete for a limited amount of anti-acyclovir monoclonal &lt;a style="font-weight: bold;" href="http://www.biosyn.com"&gt;antibody&lt;/a&gt;. The specific &lt;a style="font-weight: bold;" href="http://www.biosyn.com"&gt;antibody&lt;/a&gt; bound to the immobilized ACV was detected by the use of alkaline phosphatase conjugated anti-mouse imtnunoglobulin . Balzarini J et al., 2002 designed a number of acyclovir and ganciclovir derivatives that are endowed with intrinsic strong fluorescent characteristics by synthesizing tricyclic ACV and GCV derivatives containing an additional aromatic entity attached to the purine system .&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Structural Characteristics&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;ACV also referred to as acycloguanosine, demonstrates strong and selective activity against herpes simplex and varicellazoster viruses. ACV structure is [9-(2-hydroxyethoxy)methylguanine].  Tadepalli S et al., in 1986 synthesized 1-O-octadecyl-sn-glycero-3-phospho-acyclovir (ODG-P-ACV), 1-O-hexadecylpropanediol-3-phospho-acyclovir (HDP-P-ACV), and 1-O-octadecyl-sn-glycero-3-phospho-azidothymidine (ODG-P-AZT), and evaluated their antiviral activity in human hepatoma cells that constitutively produce HBV. Results from specificity studies showed that there was a high degree of cross-reactivity with ACV and ACV succinate, minor cross-reactivity with the primnary metabolite of ACV (9-carboxymethoxymethylguanine [CMMG]), and significant cross-reactivity with 8-hydroxy-9- (2-hydroxyethoxy)methylguanine (8-OH-ACV), a minor metabolite. 9-(2-14ydroxy-1-hydroxymethylethoxy)methylguanine (BW B759U), structurally similar to ACV, exhibited low but measurable cross-reactivity. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Mode of Action&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The mechanism of action of ACV and its bioavailability and pharmacokinetics in humans have been established for both intravenous and oral formulations of the drug. ACV triphosphate inhibit the DNA polymerase of human hepatitis B virus (HBV) by 50% at submicromolar concentrations, but no effects of ACV treatment have been noted on the clinical manifestations of hepatitis B. However, HDP-P-ACV and ODG-P-ACV inhibited viral replication by 50% at 0.5 and 6.8 μM, respectively. Based on the EC50, HDP-P-ACV, ODG-P-ACV, and ODG-P-AZT were &amp;gt; 200, &amp;gt; 14.7, and &amp;gt; 48 times more active than their free nucleosides in reducing HBV replication in 2.2.15 cells. To evaluate the biochemical basis for the increased antiviral activity, authors studied the uptake and metabolism of 1-O-octadecyl-sn-glycero-3-phospho-[3H]acyclovir (ODG-P-[3H]ACV) in HepG2 cells. Cellular uptake of ODG-P-[3H]ACV was found to be substantially greater than that of [3H]ACV, and cellular levels of ACV-mono-, -di-, and -triphosphate were much higher with ODG-P-ACV. ODG-P-[3H]ACV was well absorbed orally. Based on urinary recovery of tritium after oral or parenteral administration of the radio labeled compounds, oral absorption of ODG-P-ACV in mice was 100% versus 37% for ACV. ODG-P-ACV plasma area under the curve was more than 7-fold greater than that of ACV. Lipid prodrugs of this type is useful orally in treating viral diseases 4,5,6.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Functions&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;ACV is an antiviral drug&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;, which selectively inhibits replication of members of the herpes group of DNA viruses with low cell toxicity. This drug is used clinically in treating a variety of herpesvirus infections.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Prodrug of ACV,&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Valaciclovir (VACV), a prodrug of ACV is usually preferred in the oral treatment of viral infections, mainly herpes simplex virus (HSV).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;A number of tricyclic&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; ACV and ganciclovir (GCV) derivatives substituted with bulky lipophilic groups have been identified as potent and highly selective cytostatic agents against herpes simplex virus type (HSV-1)-thymidine kinase (TK) gene-transduced human osteosarcoma and murine mammary carcinoma tumor cells.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Effect in cell culture&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;, the tricyclic ACV derivatives were also endowed with a very pronounced bystander effect in cell culture, albeit at relatively high drug concentrations.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;ACV acts against cytomegalovirus (CMV) in general and the latter against CMV retinitis mainly via phosphorylation and inhibition of the viral DNA polymerase .&lt;br /&gt;&lt;br /&gt;For more information visit: &lt;a style="font-weight: bold;" href="http://www.biosyn.com"&gt;www.biosyn.com&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-3375096490704458286?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/3375096490704458286/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=3375096490704458286' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/3375096490704458286'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/3375096490704458286'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/acv-and-related-compounds-products.html' title='ACV and Related Compounds Products'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-6245277728076885789</id><published>2011-07-27T09:11:00.001-08:00</published><updated>2011-07-27T09:13:42.179-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Introduction to Swine Flu'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Influenza Peptide Virus'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>Introduction to Swine Flu</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/swine_flu.aspx"&gt;&lt;span style="font-weight: bold;"&gt;Introduction to Swine Flu&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The origin. It is well known that most higher organisms carry the genomes of certain viruses that normally lie dormant in a quiescent state until they become activated by different factors and causing a number of problems. However in most cases, after infecting their hosts, &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;viruses &lt;/a&gt;&lt;span style="font-family: verdana;"&gt;are cleared by an immunological response mounted by the host or eventually they kill their host this way putting an end to their replication cycle. Yet in either case, the newly produced virus can infect other hosts and start the reproductive cycle once more. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Swine Flu Transmission and Vaccine&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Transmission&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;. At this point, the infected human can get sick and transmit the virus via aerosolized micro drops of saliva produced during coughing, and he is also capable of passing the virus by direct contact with&lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt; non-infected&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; people. About vaccines against it. Currently there are not vaccines against the new swine flu virus strain and producing a vaccine can take 6-9 months. Vaccines against the influenza virus are strain specific, however because the virus has a high rate of mutations in those regions responsible for initiating the infection process there is a need to develop new vaccines every year.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tamiflu&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;This drug manufactured by Roche appears to be effective against the swine flu; influenza virus initiates the infection process by latching to sialoglycoproteins present of the cell surface via their neuraminidase. Inhibition of the &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;viral neuraminidase&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; interferes with the infection process contributing to reduce symptoms and complications.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Influenza Peptide Virus&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The influenza virus is an enveloped RNA virus and its genome is split between 7 to 8 RNA fragments, each encoding for one to two genes. This large number of &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;RNA fragments&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; allows their mixing or reassorment if more than one virus strain is infecting a cell, to yield new viral strains containing genetic information from different viral strains. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Immunity and Viral Peptide&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Although the protective immunity stimulated by the vaccines is humoral and mediated by neutralizing antibodies there is significant body of evidence pointing to the crucial role of T cell immunity. In effect, the increased susceptibility of young children and older people correlates well with a low Th1 immunity. &lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;For more information visit: &lt;/span&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com"&gt;&lt;span style="font-weight: bold;"&gt;www.biosyn.com&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-6245277728076885789?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/6245277728076885789/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=6245277728076885789' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/6245277728076885789'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/6245277728076885789'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/introduction-to-swine-flu.html' title='Introduction to Swine Flu'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-7058026777192883593</id><published>2011-07-27T07:56:00.002-08:00</published><updated>2011-07-27T08:01:28.877-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='SIRNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='siRNAs'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='RNA interference'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>SIRNA Synthesis</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/siRNA_synthesis.aspx"&gt;&lt;span style="font-weight: bold;"&gt;SIRNA Synthesis&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;Small interfering RNA&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; (siRNA), sometimes known as short interfering RNA or silencing RNA, are a class of 20-25 nucleotide-long double-stranded RNA molecules that play a variety of roles in biology. Most notably, siRNA is involved in the RNA interference (RNAi) pathway where the siRNA interferes with the expression of a specific gene. In addition to their role in the RNAi pathway, &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;siRNAs&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; also act in RNAi-related pathways, e.g. as an antiviral mechanism or in shaping the chromatin structure of a genome; the complexity of these pathways is only now being elucidated.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;siRNAs&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;siRNAs were first discovered by David Baulcombe's group in Norwich, England, as part of post-transcriptional gene silencing (PTGS) in plants, and published their findings in Science in a paper titled "A species of small antisense RNA in posttranscriptional gene silencing in plants". Shortly thereafter, in 2001, synthetic siRNAs were then shown to be able to induce RNAi in mammalian cells by Thomas Tuschl and colleagues in a paper published in Nature. This discovery led to a surge in interest in harnessing RNAi for biomedical research and drug development.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;RNA Interference&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;RNA Interference Home has everything you need for your RNAi and siRNA research. You will find information here and links on&lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt; RNAi protocols&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;, an RNAi Forum, and RNAi bioinformatic software for design of RNAi and SiRNA inhibitory molecules.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;For more information visit: &lt;/span&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com"&gt;www.biosyn.com&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-7058026777192883593?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/7058026777192883593/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=7058026777192883593' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7058026777192883593'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7058026777192883593'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/sirna-synthesis.html' title='SIRNA Synthesis'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-6102138653047194072</id><published>2011-07-27T07:48:00.004-08:00</published><updated>2011-07-27T07:54:20.234-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IRE1p Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRE1p_Antibody-4183.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IRE1p Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:3655&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Accumulation of malfolded proteins in the endoplasmic reticulum (ER) activates the unfolded protein response (UPR) and the upregulation of the ER molecular chaperones GRP78 and GRP 94 (1,2). These proteins are normally bound to ER transmembrane proteins such as IRE1p and ATF6 (3,4) but ER stress causes their dissociation. This allows IRE1p, a serine-threonine protein kinase to transduce the unfolded protein signal from the ER to the nucleus. IRE1p also has an endoribonuclease activity that is required to splice X-box binding protein (XBP1) mRNA converting it to a potent UPR transcriptional activation (5). Depletion of IRE1p through the expression of a dominant negative form of IRE1p has no effect on transfected cells, but cell death via apoptosis occurs under stress conditions that cause unfolded proteins to accumulate in the ER (6). Two alternatively spliced transcript variants encoding different isoforms have been found for this gene.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IRE1p (CT), Endoplasmic reticulum-to-nucleus signaling 1, ERN1&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C3655.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 136px; height: 185px;" src="http://www.biosyn.com/Images%5Cantibody%5C3655.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot analysis of IRE1p in A-20 cell lysate with IRE1p &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;antibody&lt;/a&gt; at (A) 0.5, (B) 1 and (C) 2 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunocytochemistry of IRE1p in A-20 cells with IRE1p &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;antibody&lt;/a&gt; at 1 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Images&lt;/b&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_205.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 286px; height: 198px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_205.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IRE1p antibody was raised against a 16 amino acid &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; from near the carboxy terminus of human IRE1p.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification: &lt;/span&gt;Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;Clonality and Clone: This is a polyclonal &lt;a href="http://www.biosyn.com/PeptideOverview.aspx"&gt;antibody&lt;/a&gt;.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host: &lt;/span&gt;IRE1p antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Immunogen:&lt;/span&gt; Human IRE1p (C-Terminus) Peptide (Cat. No. 3655P)&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application&lt;/span&gt;: IRE1p &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;antibody&lt;/a&gt; can be used for the detection of IRE1p by Western blot at 1 – 2 µg/ml.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s): &lt;/span&gt;E, WB, ICC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat. No. 3655P - IRE1p &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage: &lt;/span&gt;IRE1p antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. &lt;/span&gt;Cat. No. 1288 - A-20 Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity: &lt;/span&gt;H, M, R&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number: &lt;/span&gt;193806335&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; O75460&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description: &lt;/span&gt;(CT) Endoplasmic reticulum-to-nucleus signaling 1&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt; &lt;span style="font-weight: bold;"&gt;  1. &lt;/span&gt;Little E, Ramakrishnan M, Roy B, et al. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit. Rev. Eukaryot. Gene Expr. 1994; 4:1-18.&lt;br /&gt;  &lt;span style="font-weight: bold;"&gt; 2&lt;/span&gt;. Lee AS. The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 2005; 35:373-81.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   3. &lt;/span&gt;Bertolotti A, Zhang Y, Hendershot LM, et al. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2000; 2:326-32.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   4. &lt;/span&gt;Shen J, Chen X, Hendershot L, et al. ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev. Cell 2002; 3:99-111.&lt;br /&gt;&lt;/span&gt;                                        &lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-6102138653047194072?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/6102138653047194072/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=6102138653047194072' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/6102138653047194072'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/6102138653047194072'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/ire1p-antibody.html' title='IRE1p Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-8939948574041328491</id><published>2011-07-27T07:44:00.002-08:00</published><updated>2011-07-27T07:48:32.554-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IRAK-M Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRAK-M_Antibody-4342.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IRAK-M Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:2355&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Interleukin-1 (IL-1) and lipopolysaccharide (LPS) induces cellular response through IL-1 receptor (IL-1R) and Toll like receptors (TLR). IL-1 receptor-associated kinase (IRAK and IRAK2) mediates the activation of NF-betaB by IL-1/Toll receptors (1,2), which is a pivotal transcription factor mediating inflammatory and immune response. A novel member in the IRAK/Pelle family was recently identified and designated IRAK-M (3). IRAKs associate with IL-1/Toll receptors after IL-1 or LPS stimulation and the dominant negative mutants of IRAKs inhibit IL-1 or LPS induced NF-betaB activation. Members in IRAK/Pelle family play a central role in IL-1R/TLR mediated inflammatory responses to cytokine IL-1 and LPS.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IRAK-M&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C2355.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 116px; height: 166px;" src="http://www.biosyn.com/Images%5Cantibody%5C2355.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot analysis of IRAK-M in mouse spleen (M) and rat liver (R) tissue lysates with IRAK-M antibody at 1 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunohistochemical staining of rat liver cells using IRAK-M antibody at 2 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_54.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 208px; height: 194px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_54.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IRAK-M antibody was raised against a peptide corresponding to amino acids from the carboxy terminus of human IRAK-M .&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification:&lt;/span&gt; Affinity chromatography purified via peptide column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone:&lt;/span&gt; This is a polyclonal antibody.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host:&lt;/span&gt; IRAK-M antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Immunogen:&lt;/span&gt; Human IRAK-M Peptide (Cat. No. 2355P)&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; IRAK-M antibody can be used for detection of IRAK-M by Western blot at 0.5 to 1 µg/ml.A 68 kDa major band can be detected. IRAK-M antibody can also detect IRAK-M by immunohistochemistry at 2 µg/ml.IRAK-M antibody has no cross response to IRAK or IRAK2.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s):&lt;/span&gt; E, WB, IHC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat. No. 2355P - IRAK-M Peptide&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; IRAK-M antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. Cat. No. &lt;/span&gt;1406 - Mouse Spleen Tissue Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;2. Cat. No.&lt;/span&gt; 1465 - Rat Kidney Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity:&lt;/span&gt; H, M, R&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number:&lt;/span&gt; 5225377&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; AF113136&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; A novel IL-1R Associated Kinase&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;   &lt;span style="font-weight: bold;"&gt;1.&lt;/span&gt; Cao Z; Henzel WJ; Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 1996;271:1128-31.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2. &lt;/span&gt;Muzio M, Ni J, Feng P, Dixit VM. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997;278:1612-5&lt;br /&gt;   &lt;span style="font-weight: bold;"&gt;3.&lt;/span&gt; Wesche H, Gao X, Li X, Kirschning CJ, Stark GR, Cao Z. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem. 1999;274(27):19403-10.&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-8939948574041328491?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/8939948574041328491/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=8939948574041328491' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/8939948574041328491'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/8939948574041328491'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/irak-m-antibody.html' title='IRAK-M Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-3936349968194637772</id><published>2011-07-27T07:38:00.003-08:00</published><updated>2011-07-27T07:44:36.729-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IRAK-4 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-weight: bold;" href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRAK-4_Antibody-4225.aspx"&gt;IRAK-4 Antibody&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:3125&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Interleukin-1 (IL-1) and lipopolysaccharide (LPS) induces cellular responses through IL-1 receptor (IL-1R) and Toll-like receptors (TLR). IL-1R-associated kinases (IRAK, IRAK2, and IRAK-M) regulate the activation of NF-kappaB and MAP kinase (MAPK) by IL-1R/TLR (1-3). A novel member in the IRAK/Pelle family was recently identified and designated IRAK-4 (4,5). Overexpression of IRAK-4 activates NF-kB and MAPK pathways. IRAK-4 interacts with and phosphorylates IRAK-1. IRAK-4-deficient animals are completely resistant to the challenge with LPS. Animals and humans lacking IRAK-4 are impaired in their responses to viral and bacterial challenges (5,6). Members in IRAK/Pelle family play a central role in IL-1R/TLR mediated inflammatory responses and in innate immunity.&lt;/span&gt;&lt;br /&gt;&lt;strong style="font-family: verdana;"&gt;&lt;br /&gt;Additional Names: &lt;/strong&gt;&lt;span style="font-family: verdana;"&gt;IRAK-4&lt;/span&gt;&lt;br /&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C3125.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 123px; height: 187px;" src="http://www.biosyn.com/Images%5Cantibody%5C3125.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt;&lt;span style="font-family: verdana;"&gt; Western blot  analysis of IRAK-4 in HeLa cell lysate with IRAK-4 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at 1 (lane  1), 2 (lane 2), and 4 (lane 3) µg/ml, respectively.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Below:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Immunocytochemistry of IRAK-4 in K562 cells with IRAK-4 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at 10 µg/ml.                                                                                 &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5Cd_153.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 226px; height: 240px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_153.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;IRAK-4 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a synthetic &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; corresponding to amino acids at the carboxy terminus of human IRAK-4.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Purification: Affinity chromatography purified via peptide column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Clonality and Clone: This is a polyclonal antibody.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Host: IRAK-4 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Immunogen: Human IRAK4 Peptide (Cat. No. 3125P)&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Application: IRAK-4 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for the detection of IRAK-4 by Western blot at 1 to 2 µg/ml.A 50 kDa band can be detected. Anti-IRAK-4 has no cross response to other IRAKs.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Tested Application(s): E, WB, ICC&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Blocking Peptide:Cat. No. 3125P - IRAK-4 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Long-Term Storage: IRAK-4 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;1. Cat. No. 1204 - K562 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Species Reactivity: H&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;GI Number: 20219010&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Accession Number: AAM15772&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Short Description: A member in IRAK/Pelle family&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   1. Cao Z; Henzel WJ; Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 1996;271:1128-31.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   2. Muzio M, Ni J, Feng P, Dixit VM. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997;278:1612-5&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   3. Wesche H, Gao X, Li X, Kirschning CJ, Stark GR, Cao Z. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem. 1999;274(27):19403-10.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   4. Li S, Strelow A, Fontana EJ, Wesche H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci USA . 2002;99(8):5567-72.&lt;/span&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-3936349968194637772?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/3936349968194637772/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=3936349968194637772' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/3936349968194637772'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/3936349968194637772'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/irak-4-antibody.html' title='IRAK-4 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-5208425362173006630</id><published>2011-07-19T07:37:00.000-08:00</published><updated>2011-07-19T07:46:15.966-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='DNA Structure'/><category scheme='http://www.blogger.com/atom/ns#' term='DNA Structure Animation'/><category scheme='http://www.blogger.com/atom/ns#' term='DNA Replication'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='DNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>DNA Structure Animation</title><content type='html'>&lt;div style="text-align: center; font-weight: bold; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/dna_structure_animation.aspx"&gt;DNA Structure Animation&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;For over 20 years, &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;BioSynthesis&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; has provided custom &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;oligonucleotide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; production services worldwide, including researcher at university, biotechnology and pharmaceutical institutions. We offer wide variety of oligo modifications and labelings from small discovery research scale to multi-gram ASR/cGMP for clinical diagnostic production. As always, quality is guaranteed!&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;DNA Structure&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;DNA has a compact, highly organized structure that is reminiscent of a spiral staircase. There are several structural characteristics that are readily identifiable in &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;DNA&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;DNA Synthesis&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;At bio-Synthesis any synthesis of DNA that happens outside the s phase of the cell cycle. The term is to describe the replication of dna during the nucleotide excision repair of dna damage and thus distinct from the semi-conservative replication of dna which is confined to the s-phase of the eukaryotic cell cycle.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;DNA Replication&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;DNA replication is the process of copying a double-stranded DNA molecule to form two double-stranded molecules. The process of &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;DNA replication&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; is a fundamental process used by all living organisms as it is the basis for biological inheritance. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;For more Information visit: &lt;/span&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com"&gt;&lt;span style="font-weight: bold;"&gt;www.biosyn.com&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-5208425362173006630?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/5208425362173006630/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=5208425362173006630' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5208425362173006630'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5208425362173006630'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/dna-structure-animation.html' title='DNA Structure Animation'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-4751890109319052983</id><published>2011-07-19T07:32:00.004-08:00</published><updated>2011-07-19T07:36:39.444-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IRAK-2 Antibody</title><content type='html'>&lt;span style="font-size:100%;"&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5Cd_126.gif"&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRAK-2_Antibody-4785.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IRAK-2 Antibody&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog&lt;/span&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRAK-2_Antibody-4785.aspx"&gt;&lt;span style="font-weight: bold;"&gt;#:2213&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The pro-inflammatory cytokine IL-1 induces cellular response through two subunits of its receptor, IL-1 receptor I (IL-1RI) and IL-1 receptor accessory protein (IL-1RAcP). IL-1 receptor-associated kinase (IRAK) mediates activation of NF-kappaB , which is a pivotal transcription factor mediating inflammatory and immune response. A novel member in the IRAK/Pelle family was recently identified and designated IRAK2 (2). Both IRAK and IRAK2 recruit to the subunits of the IL-1R complex after IL-1 binding and lead to NF-kappaB activation. IRAKs also associate with Toll-like receptor (TLR) and the dominant negative mutants of IRAKs inhibit LPS-induced NF-kappaB activation (3,4). Members in IRAK/Pelle family play a central role in IL-1R and TLR mediated inflammatory responses to cytokine IL-1 and LPS. IRAK2 is expressed in a variety of human tissues.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IRAK-2 (CT), IRAK-2&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C2213.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 108px; height: 159px;" src="http://www.biosyn.com/Images%5Cantibody%5C2213.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of IRAK2 in K562 whole cell lysate with IRAK2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at 1:500 dilution.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Below:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Immunofluorescence of IRAK2 in HeLa cells with IRAK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at 10 µg/ml.                                                                                 &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5Cd_126.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 172px; height: 169px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_126.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IRAK2 antibody was raised against a &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; corresponding to amino acids near the carboxy terminus of human IRAK2.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Affinity chromatography purified via peptide column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IRAK-2 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Immunogen:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Human IRAK2 (C-Terminus) &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; (Cat. No. 2213P)&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IRAK-2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for detection of IRAK2 by Western blot at 1:500 to 1:1000 dilution. A 65 kDa band can be detected. Anti-IRAK2 has no cross response to IRAK.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s):&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; E, WB, IF&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat. No. 2213P - IRAK-2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IRAK-2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1.Cat. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;No. 1204 - K562 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;2. Cat. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;No. 1201 - HeLa Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; H&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;37725373&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; AAO24761&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; (CT) IL-1R Associated Kinase&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   1. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cao Z; Henzel WJ; Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 1996;271:1128-31.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;  2.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Muzio M, Ni J, Feng P, Dixit VM. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997;278:1612-5&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, Mantovani A, Rothe M, Muzio M, Arditi M. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 1999;274:7611-4&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   4. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Yang RB, Mark MR, Gurney AL , Godowski PJ. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J Immunol 1999;163:639-43 (RD0300)&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-4751890109319052983?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/4751890109319052983/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=4751890109319052983' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4751890109319052983'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4751890109319052983'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/irak-2-antibody.html' title='IRAK-2 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-4557764750163640035</id><published>2011-07-19T07:20:00.003-08:00</published><updated>2011-07-19T07:32:31.114-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IRAK2 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRAK2_Antibody-4190.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IRAK2 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:3597&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The pro-inflammatory cytokine IL-1 induces cellular response through two subunits of its receptor, IL-1 receptor I (IL-1RI) and IL-1 receptor accessory protein (IL-1RAcP). IL-1 receptor-associated kinase (IRAK) mediates activation of NF-kappaB, which is a pivotal transcription factor mediating inflammatory and immune response. A novel member in the IRAK/Pelle family has been identified and designated IRAK2 (1). Both IRAK and IRAK2 recruit to the subunits of the IL-1R complex after IL-1 binding and lead to NF-kappaB activation. IRAKs also associate with Toll like receptor (TLR) and the dominant negative mutants of IRAKs inhibit LPS-induced NF-?B activation (2,3). Members in IRAK/Pelle family play a central role in IL-1R and TLR mediated inflammatory response. Unlike human IRAK2, murine IRAK2 exists as four alternately spliced isoforms (IRAK2a-d), with two isoforms (IRAK2c and d) acting in an inhibitory fashion (4). IRAK2 is expressed in a variety of tissues.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IRAK2 (C2), mIRAK2&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C3597.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 164px; height: 188px;" src="http://www.biosyn.com/Images%5Cantibody%5C3597.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of IRAK2 in A-20 whole cell lysate with IRAK2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; (C2) at (A) 0.5, (B) 1, and (C) 2 µg/ml.                                                                              &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;RAK2 antibody was raised against a &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; corresponding to 16 amino acids near the carboxy-terminus of mouse IRAK2a which is common to all four isoforms. Anti-IRAK2 is mouse specific.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Affinity chromatography purified via &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IRAK2 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Immunogen:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Human IRAK2 (C-Terminus 2) &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; (Cat. No. 3597P)&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IRAK2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for detection of mouse IRAK2 by Western blot at 0.5 - 1 µg/ml.Anti-IRAK2 has no cross response to IRAK.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s): &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;E, WB&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat. No. 3597P - IRAK2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IRAK2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. Cat. No.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; 1288 - A-20 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; M&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;37725373&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; AAO24761&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; (C2) mouse IL-1R associated kinase&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;  &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt; 1. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Muzio M, Ni J, Feng P, et al. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997; 278:1612-5.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   2.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Zhang FX, Kirschning CJ, Mancinelli R, et al. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 1999; 274:7611-4.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Yang RB, Mark MR, Gurney AL, et al. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J. Immunol. 1999; 163:639-43.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   4.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Hardy MP and O’Neill LAJ. The murine IRAK2 gene encodes four alternately spliced isoforms, two of which are inhibitory. J. Biol. Chem. 2004; 279:27699-708.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-4557764750163640035?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/4557764750163640035/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=4557764750163640035' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4557764750163640035'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4557764750163640035'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/irak2-antibody_19.html' title='IRAK2 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-376312506418925138</id><published>2011-07-19T07:11:00.005-08:00</published><updated>2011-07-19T07:20:03.597-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IRAK2 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRAK2_Antibody-4189.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IRAK2 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:3595&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The pro-inflammatory cytokine IL-1 induces cellular response through two subunits of its receptor, IL-1 receptor I (IL-1RI) and IL-1 receptor accessory protein (IL-1RAcP). IL-1 receptor-associated kinase (IRAK) mediates activation of NF-kappaB, which is a pivotal transcription factor mediating inflammatory and immune response. A novel member in the IRAK/Pelle family has been identified and designated IRAK2 (1). Both IRAK and IRAK2 recruit to the subunits of the IL-1R complex after IL-1 binding and lead to NF-kappaB activation. IRAKs also associate with Toll like receptor (TLR) and the dominant negative mutants of IRAKs inhibit LPS-induced NF-?B activation (2,3). Members in IRAK/Pelle family play a central role in IL-1R and TLR mediated inflammatory response. Unlike human IRAK2, murine IRAK2 exists as four alternately spliced isoforms (IRAK2a-d), with two isoforms (IRAK2c and d) acting in an inhibitory fashion (4). IRAK2 is expressed in a variety of tissues.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IRAK2 (CT), mIRAK2&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C3595.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 173px; height: 180px;" src="http://www.biosyn.com/Images%5Cantibody%5C3595.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of IRAK2 in RAW264.7 whole cell lysate with mIRAK2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at (A) 0.5, (B) 1, and (C) 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Below:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Immunocytochemistry of IRAK2 in A-20 cells with IRAK2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at 1 µg/ml.                                                                                 &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5Cd_197.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 270px; height: 240px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_197.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IRAK2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; corresponding to 17 amino acids near the carboxy-terminus of mouse IRAK2a which is common to all four isoforms. mIRAK2 antibody will also recognize human IRAK2.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Affinity chromatography purified via &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IRAK2 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-mouse secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Immunogen: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Human IRAK2 (C-Terminus) &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; (Cat. No. 3595P)&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IRAK2 antibody can be used for detection of mouse IRAK2 by Western blot at 0.5 - 1 µg/ml.A 65 kDa band should be detected. Anti-IRAK2 has no cross response to IRAK. Anti-IRAK2 will also recognize human IRAK2.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s): &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;E, WB, ICC&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat. No. 3595P - IRAK2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IRAK2 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. Cat.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; No. 1283 - RAW264.7 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;2. Cat.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; No. 1288 - A-20 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; H, M&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;37725373&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; AAO24761&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; (CT) mouse IL-1R associated kinase&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;  1.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Muzio M, Ni J, Feng P, et al. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997; 278:1612-5.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   2.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Zhang FX, Kirschning CJ, Mancinelli R, et al. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 1999; 274:7611-4.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   3. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Yang RB, Mark MR, Gurney AL, et al. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J. Immunol. 1999; 163:639-43.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   4. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Hardy MP and O’Neill LAJ. The murine IRAK2 gene encodes four alternately spliced isoforms, two of which are inhibitory. J. Biol. Chem. 2004; 279:27699-708.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-376312506418925138?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/376312506418925138/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=376312506418925138' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/376312506418925138'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/376312506418925138'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/irak2-antibody.html' title='IRAK2 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-2038827706014539323</id><published>2011-07-13T07:26:00.002-08:00</published><updated>2011-07-13T07:32:28.575-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Biological Agents'/><category scheme='http://www.blogger.com/atom/ns#' term='Extinct Biological Hazard Organisms'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Biological Hazard'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>Extinct Biological Hazard Organisms</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/extinct_biological_hazard_organisms.aspx"&gt;&lt;span style="font-weight: bold;"&gt;Extinct Biological Hazard Organisms      &lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;Biosynthesis DNA Testing&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; (Ancestry/DNA Identity Profile) provides you with a simple and objective description of your deep ancestral origins as well as a certificate of your unique genetic fingerprint. The test gives you an estimated percentage of ancestry from the four major historical population groups.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Biological Hazard&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;A biological hazard or biohazard is an organism, or substance derived from an organism, that poses a threat to (primarily) human health. This can include medical waste or samples of a microorganism, virus or toxin (from a biological source) that can impact human health. It can also include substances harmful to animals. The term and its associated symbol is generally used as a warning, so that those potentially exposed to the substances will know to take precautions. There is also a &lt;a style="font-weight: bold;" href="http://www.biosyn.com"&gt;biohazard HCS/WHMIS&lt;/a&gt; logo which utilizes the same symbol.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Biological Agents&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;Biological agents&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; include prions, viruses, microorganisms (bacteria and fungi) and some unicellular and multicellular eukaryotes (for example parasites) and their associated toxins. They have the ability to adversely affect human health in a variety of ways, ranging from allergic reactions that are usually relatively mild, to serious medical conditions, even death. These organisms are ubiquitous in the natural environment; they are found in water, soil, plants, and animals.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;For more information visit: &lt;/span&gt;&lt;a style="font-family: verdana; font-weight: bold;" href="http://www.biosyn.com"&gt;www.biosyn.com&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-2038827706014539323?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/2038827706014539323/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=2038827706014539323' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/2038827706014539323'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/2038827706014539323'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/extinct-biological-hazard-organisms.html' title='Extinct Biological Hazard Organisms'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-1848026175578595935</id><published>2011-07-13T07:22:00.003-08:00</published><updated>2011-07-13T07:25:53.511-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IRAK Monoclonal Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRAK_Monoclonal_Antibody-4832.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IRAK Monoclonal Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:PM-5317&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Nuclear factor kappa B (NF-kappaB) is a ubiquitous transcription factor and an essential mediator of gene expression during activation of immune and inflammatory responses. NF-kappaB mediates the expression of a great variety of genes in response to extracellular stimuli including IL-1, TNFalpha and LPS. A serine/threonine protein kinase associated with IL-1 receptor (IRAK) and its homologue mouse pelle-like protein kinase (mPLK) were identified recently. IRAK is associated with the IL-1 receptor subunits IL-1RI and IL-1RAcP after IL-1 binding and serves as a signaling molecule to mediate IL-1 response. IRAK mediates a signaling cascade leading to NF-kB activation by members in IL-1 family including IL-1 and a novel cytokine IL-18 (also termed IGIF).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong style="font-family: verdana;"&gt;Additional Names: &lt;/strong&gt;&lt;/span&gt;                            &lt;span style="font-size:100%;"&gt;&lt;span style="font-family: verdana;"&gt;IRAK (8F1A7),IL-1-Receptor Associated Kinase&lt;/span&gt;&lt;br /&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5CPM-5317.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 169px; height: 305px;" src="http://www.biosyn.com/Images%5Cantibody%5CPM-5317.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of IRAK in mouse liver lysate with IRAK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at (A) 1 and (B) 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Mouse monoclonal IRAK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a recombinant protein corresponding to amino acids 618 - 712 of human IRAK.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Immunoaffinity chromotography purified IgG&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a monoclonal &lt;/span&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;. (Clone 8F1A7)&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IRAK monoclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised in mouse.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-mouse secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Immunogen:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Recombinant protein corresponding to amino acids 618 - 712 of human IRAK.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IRAK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for Western blot at 1 - 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s):&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; E, WB&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IRAK monoclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be stored at 4ºC, stable for one year.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. Cat. No.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; 95-112 - IRAK Recombinant Protein&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; H, M&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IL-1-Receptor Associated Kinase&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;  1. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cao Z,; Henzel WJ, and Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 1996; 271:1128-31.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   2. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Trofimova M, Sprenkle AB, Green M; et al. Developmental and tissue-specific expression of mouse pelle-like protein kinase. J. Bio. Chem. 1996; 271: 17609-12.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Jianing Huang, Xiong Gao, Shyun Li, et al. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin-1 receptor accessory protein. Proc. Natl. Acad. Sci. USA 1997; 94:12829-32.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;  4. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Robinson D, Shibuya K, Mui A, et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NF-kB. Immunity 1997; 7:571-81.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;                                                                                                                                                                                                                                              &lt;div style="font-family: verdana;" class="npdet_box2"&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-1848026175578595935?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/1848026175578595935/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=1848026175578595935' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/1848026175578595935'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/1848026175578595935'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/irak-monoclonal-antibody_13.html' title='IRAK Monoclonal Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-7171617955273303310</id><published>2011-07-13T07:18:00.003-08:00</published><updated>2011-07-13T07:22:09.399-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IRAK Monoclonal Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRAK_Monoclonal_Antibody-4831.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IRAK Monoclonal Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#:&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;PM-5315&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Nuclear factor kappa B (NF-kappaB) is a ubiquitous transcription factor and an essential mediator of gene expression during activation of immune and inflammatory responses. NF-kappaB mediates the expression of a great variety of genes in response to extracellular stimuli including IL-1, TNFalpha and LPS. A serine/threonine protein kinase associated with IL-1 receptor (IRAK) and its homologue mouse pelle-like protein kinase (mPLK) were identified recently. IRAK is associated with the IL-1 receptor subunits IL-1RI and IL-1RAcP after IL-1 binding and serves as a signaling molecule to mediate IL-1 response. IRAK mediates a signaling cascade leading to NF-kB activation by members in IL-1 family including IL-1 and a novel cytokine IL-18 (also termed IGIF).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IRAK (1F12C1),IL-1-Receptor Associated Kinase&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5CPM-5315.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 169px; height: 212px;" src="http://www.biosyn.com/Images%5Cantibody%5CPM-5315.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of IRAK in HeLa lysates with IRAK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody &lt;/a&gt;&lt;span style="font-family: verdana;"&gt;at (A) 1 and (B) 2 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Mouse monoclonal IRAK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody &lt;/a&gt;&lt;span style="font-family: verdana;"&gt;was raised against a recombinant protein corresponding to amino acids 618 - 712 of human IRAK.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Immunoaffinity chromotography purified IgG&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a monoclonal antibody. (Clone 1F12C1)&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IRAK monoclonal antibody was raised in mouse.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-mouse secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Immunogen:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Recombinant protein corresponding to amino acids 618 - 712 of human IRAK.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;RAK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody &lt;/a&gt;&lt;span style="font-family: verdana;"&gt;can be used for Western blot at 1 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s): &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;E, WB&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IRAK monoclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody &lt;/a&gt;&lt;span style="font-family: verdana;"&gt;can be stored at 4ºC, stable for one year.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. Cat&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;. No. 95-112 - IRAK Recombinant Protein&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; H, M&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IL-1-Receptor Associated Kinase&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   1.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Cao Z,; Henzel WJ, and Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 1996; 271:1128-31.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   2. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Trofimova M, Sprenkle AB, Green M; et al. Developmental and tissue-specific expression of mouse pelle-like protein kinase. J. Bio. Chem. 1996; 271: 17609-12.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;  &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt; 3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Jianing Huang, Xiong Gao, Shyun Li, et al. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin-1 receptor accessory protein. Proc. Natl. Acad. Sci. USA 1997; 94:12829-32.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   4. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Robinson D, Shibuya K, Mui A, et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NF-kB. Immunity 1997; 7:571-81.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-7171617955273303310?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/7171617955273303310/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=7171617955273303310' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7171617955273303310'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7171617955273303310'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/irak-monoclonal-antibody.html' title='IRAK Monoclonal Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-7180003603209359354</id><published>2011-07-13T07:08:00.003-08:00</published><updated>2011-07-13T07:18:01.083-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IRAK Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IRAK_Antibody-3861.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IRAK Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;#:1007&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Nuclear factor kappa B (NF-kappaB) is a ubiquitous transcription factor and an essential mediator of gene expression during activation of immune and inflammatory responses. NF-kappaB mediates the expression of a great variety of genes in response to extracellular stimuli including IL-1, TNFalpha and LPS. A serine/threonine protein kinase associated with IL-1 receptor (IRAK) and its homologue mouse pelle-like protein kinase (mPLK) were identified recently. IRAK is associated with the IL-1 receptor subunits IL-1RI and IL-1RAcP after IL-1 binding and serves as a signaling molecule to mediate IL-1 response. IRAK mediates a signaling cascade leading to NF-kappaB activation by members in IL-1 family including IL-1 and a novel cytokine IL-18 (also termed IGIF).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IRAK (CT), IL-1-Receptor Associated Kinase&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C1007.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 133px; height: 210px;" src="http://www.biosyn.com/Images%5Cantibody%5C1007.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;/span&gt;                                       &lt;span style="font-size:100%;"&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of IRAK in THP-1 (THP) and HeLa (HL) whole cell lysates with IRAK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at 1:2000 dilution.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Below:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Immunocytochemistry of IRAK in HeLa cells with IRAK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at 10 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Other Product Images&lt;/b&gt;&lt;/span&gt;                                                                            &lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5Cd_811.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 252px; height: 240px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_811.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IRAK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; corresponding to amino acids near the carboxy terminus of human IRAK.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Antibody is DEAE purified&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IRAK antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Immunogen:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Human IRAK (C-Terminus) &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; (Cat. No. 1007P)&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IRAK antibody can be used for Western blot at 1:1000 dilution and for immunoprecipitation with 2 to 4 ug per sample. An 80 kDa band should be detected in the lysate from non-activated cells. It has no cross response to IRAK2.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s):&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; E, WB, ICC, IP&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat. No. 1007P - IRAK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IRAK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. Cat. No.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; 1201 - HeLa Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;2. Cat. No. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;1208 - THP-1 Whole Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;H, M, R&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; 8928535&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;P51617&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; (CT) IL-1R associated kinase&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cao Z; Henzel WJ; Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 1996;271:1128-31.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   2. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Trofimova M; Sprenkle AB; Green M; Sturgill TW; Goebl MG; Harrington MA. Developmental and tissue-specific expression of mouse pelle-like protein kinase. J Bio Chem 1996; 271: 17609-1&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   3. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Jianing Huang, Xiong Gao, Shyun Li, and Zhaodan Cao. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin-1 receptor accessory protein. Proc Natl Acad Sci USA 1997;94:12829-12832&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   4.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Menon S, Kastelein R, Bazan F, O'Garra A. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NF-kappaB. Immunity 1997;7:571-581&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-7180003603209359354?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/7180003603209359354/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=7180003603209359354' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7180003603209359354'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7180003603209359354'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/irak-antibody.html' title='IRAK Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-5627434022119988018</id><published>2011-07-06T08:47:00.002-08:00</published><updated>2011-07-06T08:49:54.924-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>DNA Sequence</title><content type='html'>&lt;div  style="text-align: center;font-family:verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/dna_sequence.aspx"&gt;&lt;span style="font-weight: bold;"&gt;DNA Sequence   &lt;/span&gt;&lt;/a&gt; &lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-family: verdana; font-weight: bold;" href="http://www.biosyn.com/"&gt;BIO-SYNTHESIS&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; is second to none in its ability to meet our customer's needs, often providing modified DNA with wide variety of selections. BSI offer PNA/DNA chimera &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/"&gt;synthesis &lt;/a&gt;&lt;span style="font-family:verdana;"&gt;at competitive prices and quick delivery. Bio-Synthesis continued to provide quality DNA products and services for the research community, but it has also become a world leader in providing &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/"&gt;custom peptide products&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; and services.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;DNA Sequence&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;A DNA sequence or genetic sequence is a succession of letters representing the primary structure of a real or hypothetical DNA molecule or strand, with the capacity to carry information. The possible letters are A, C, G, and T, representing the four nucleotide subunits of a DNA strand - adenine, cytosine, guanine, thymine bases covalently linked to phospho-backbone. In the typical case, the sequences are printed abutting one another without gaps, as in the sequence AAAGTCTGAC, going from 5' to 3' from left to right. A succession of any number of nucleotides greater than four is liable to be called a sequence.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;DNA&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;The concept was to mimic an &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/"&gt;oligonucleotide&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; binding to double stranded DNA via Hoogsteen base pairing in the major groove. Thus the nucleobases of DNA were retained, but the deoxyribose phosphodiester backbone of DNA was replaced by a pseudo-peptide backbone that according to computer model building was homomorphous with the DNA backbone.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;Deoxyribonucleic Acid&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/"&gt;Deoxyribonucleic acid (DNA)&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; is a nucleic acid that contains the genetic instructions used in the development and functioning of all known living organisms and some viruses. The main role of DNA molecules is the long-term storage of information.&lt;/span&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-5627434022119988018?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/5627434022119988018/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=5627434022119988018' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5627434022119988018'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5627434022119988018'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/dna-sequence-bio-synthesis-is-second-to.html' title='DNA Sequence'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-1263735032755014207</id><published>2011-07-06T08:43:00.003-08:00</published><updated>2011-07-06T08:46:22.637-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'></title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IL-34_Antibody-4425.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IL-34 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:4781&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Interleukin-34 (IL-34) was identified through a functional screening of a library of secreted proteins after transfection of an embryonic kidney cell line with recombinant cDNAs. Flow cytometry and monocyte viability assays demonstrated increased survival and/or proliferation of monocytes induced by IL-34 and specific binding of IL-34 to CD14+ monocytes. IL-34 is a second ligand to the colony stimulating factor (CSF)-1 receptor in addition to CSF1. Like CSF1, IL-34 stimulates phosphorylation of ERK1 and ERK2 in human monocytes and induces differentiation of bone marrow cells into macrophages. Despite its predicted molecular weight, IL-34 will often run at higher molecular weight in SDS-PAGE.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IL-34 (IN), Interleukin-34&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C4781.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 168px; height: 207px;" src="http://www.biosyn.com/Images%5Cantibody%5C4781.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Western blot  analysis of IL-34 in human brain tissue lysate with IL-34 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at  0.25 µg/ml in (A) the absence and (B) the presence of blocking &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.                                                                              &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IL-34 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a 13 amino acid &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; from near the center of human IL-34.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Affinity chromatography purified via &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IL-34 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IL-34 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for the detection of IL-34 by Western blot at 0.25 – 0.5 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s): &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;E, WB&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat.No. 4781P - IL-34 Peptide&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IL-34 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1.Cat. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;No. 1303 - Human Brain Tissue Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; H, M, R&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;187610438&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;ACD13474&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; (IN) Interleukin 34&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   1. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Lin H, Lee E, Hestir K, et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008; 320:807-11.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-1263735032755014207?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/1263735032755014207/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=1263735032755014207' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/1263735032755014207'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/1263735032755014207'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/il-34-antibody-catalog-4781-interleukin.html' title=''/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-5799432910712112326</id><published>2011-07-06T08:37:00.002-08:00</published><updated>2011-07-06T08:42:53.472-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'></title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IL-34_Antibody-4603.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IL-34 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-family: verdana;font-size:100%;" &gt;&lt;br /&gt;Catalog#&lt;span style="font-weight: bold;"&gt;:4779&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Interleukin-34 (IL-34) was identified through a functional screening of a library of secreted proteins after transfection of an embryonic kidney cell line with recombinant cDNAs. Flow cytometry and monocyte viability assays demonstrated increased survival and/or proliferation of monocytes induced by IL-34 and specific binding of IL-34 to CD14+ monocytes. IL-34 is a second ligand to the colony stimulating factor (CSF)-1 receptor in addition to CSF1. Like CSF1, IL-34 stimulates phosphorylation of ERK1 and ERK2 in human monocytes and induces differentiation of bone marrow cells into macrophages. Despite its predicted molecular weight, IL-34 will often run at higher molecular weight in SDS-PAGE.&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IL-34 (NT), Interleukin-34&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C4779.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 168px; height: 306px;" src="http://www.biosyn.com/Images%5Cantibody%5C4779.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt; Western blot  analysis of IL-34 in human brain tissue lysate with IL-34 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at  0.25 µg/ml in (A) the absence and (B) the presence of blocking &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IL-34 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; was raised against a 16 amino acid &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; from near the amino terminus of human IL-34.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification: &lt;/span&gt;Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone: &lt;/span&gt;This is a polyclonal &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host:&lt;/span&gt; IL-34 antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; IL-34 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be used for the detection of IL-34 by Western blot at 0.25 – 0.5 µg/ml.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s): &lt;/span&gt;E, WB&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat.No. 4779P - IL-34 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; IL-34 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. &lt;/span&gt;Cat. No. 1303 - Human Brain Tissue Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity: &lt;/span&gt;H, M, R&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number: &lt;/span&gt;187610438&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; ACD13474&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description&lt;/span&gt;: (NT) Interleukin 34&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   1. &lt;/span&gt;Lin H, Lee E, Hestir K, et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008; 320:807-11.&lt;br /&gt;&lt;/span&gt;                                         &lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-5799432910712112326?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/5799432910712112326/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=5799432910712112326' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5799432910712112326'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5799432910712112326'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/il-34-antibody-catalog-4779-interleukin.html' title=''/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-4447795932379427668</id><published>2011-07-06T08:31:00.002-08:00</published><updated>2011-07-06T08:37:09.956-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'></title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IL-32_Antibody-4416.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IL-32 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:3751&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Interleukin-32 (IL-32) was initially identified as a transcript (NK4) that is selectively expressed in lymphocytes and NK cells and whose expression is increased following activation by IL-2 . It was later re-isolated from an IL-18-treated lung carcinoma cell line and re-named IL-32 (2). IL-32 is unusual in that it does not share sequence homology with known cytokine families and is highly expressed in immune tissues, existing in at least four differentially spliced isoforms. Because treatment of human monocytic and mouse macrophage cells with IL-32 induces several proinflammatory cytokines such as TNF-alpha, IL-8 and MIP-2, and because it is also induced in human peripheral lymphocyte cells after mitogen stimulation and in epithelial cells by IFNgamma, it has been suggested that IL-32 may play a role in autoimmune and inflammatory diseases such as rheumatoid arthritis (3).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IL-32 (IN), Interleukin 32&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C3751.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 108px; height: 179px;" src="http://www.biosyn.com/Images%5Cantibody%5C3751.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of IL-32 in Jurkat cell lysate with IL-32 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at (A) 2.5 and (B) 5 µg/ml.                                                                              &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;:IL-32 antibody was raised against a 16 amino acid peptide from near the center of human IL-32.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Affinity chromatography purified via peptide column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;: This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IL-32 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Immunogen: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Human IL-32 (Intermediate Domain) Peptide (Cat. No. 3751P)&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IL-32 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for the detection of IL-32 by Western blot at 2.5 – 5 µg/ml.This antibody detects the largest isoform of IL-32.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s)&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;: E, WB&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;Antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat. No. 3751P - IL-32 Peptide&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IL-32 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat. No. 1205 - Jurkat Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; H, M&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; 14424787&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; AAH09401&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;(IN) Interleukin 32&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   1. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Dahl CA, Schall RP, He HL, et al. Identification of a novel gene expressed in activated natural killer cells and T cells. J. Immunol. 1992; 148:597-603.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   2. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Kim S-H, Han S-Y, Azam T, et al. Interleukin-32: a cytokine and inducer of TNF-a. Immunity 2005; 22:131-42.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Cagnard N, Letourneur F, Essabbani A, et al. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur. Cyto. Network 2005; 16:289-92.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-4447795932379427668?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/4447795932379427668/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=4447795932379427668' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4447795932379427668'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4447795932379427668'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/07/il-32-antibody-catalog-3751-interleukin.html' title=''/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-1136478403556251523</id><published>2011-06-30T09:24:00.000-08:00</published><updated>2011-06-30T09:30:14.945-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='DNA Sequence Analysis'/><category scheme='http://www.blogger.com/atom/ns#' term='Recombinant DNA'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='DNA sequencing'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>DNA Sequence Analysis</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/dna_sequence_analysis.aspx"&gt;&lt;span style="font-weight: bold;"&gt;DNA Sequence Analysis&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;For over 20 years, &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;BioSynthesis&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; has provided custom &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/CustomOligos.aspx"&gt;oligonucleotide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; production services worldwide, including researcher at university, biotechnology and pharmaceutical institutions. We offer wide variety of oligo modifications and labelings from small discovery research scale to multi-gram ASR/cGMP for clinical diagnostic production. We offer design and synthesis of oligonucleotide primers and probes, also provides full range of DNA microarray printing, processing and analysis. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;DNA Sequencing&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The term DNA sequencing encompasses biochemical methods for determining the order of the nucleotide bases, adenine, guanine, cytosine, and thymine, in a &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/CustomOligos.aspx"&gt;DNA oligonucleotide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;. The sequence of DNA constitutes the heritable genetic information in nuclei, plasmids, mitochondria, and chloroplasts that forms the basis for the developmental programs of all living organisms.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Chain-termination Methods&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;While the chemical sequencing method of Maxam and Gilbert, and the plus-minus method of Sanger and Coulson were orders of magnitude faster than previous methods, the chain-terminator method developed by Sanger was even more efficient, and rapidly became the method of choice. The Maxam-Gilbert technique requires the use of highly toxic chemicals, and large amounts of&lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt; radiolabeled DNA&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;, whereas the chain-terminator method uses fewer toxic chemicals and lower amounts of radioactivity. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Recombinant DNA&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Recombinant &lt;/span&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com"&gt;DNA&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; is a man-made DNA sequence that has been assembled from other DNA sequences. They can be transformed into organisms in the form of plasmids or in the appropriate format, by using a viral vector.&lt;/span&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-1136478403556251523?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/1136478403556251523/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=1136478403556251523' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/1136478403556251523'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/1136478403556251523'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/dna-sequence-analysis.html' title='DNA Sequence Analysis'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-7552718546521411975</id><published>2011-06-30T09:18:00.003-08:00</published><updated>2011-06-30T09:22:44.165-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IL-32 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IL-32_Antibody-4415.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IL-32 Antibody&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:3749&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Interleukin-32 (IL-32) was initially identified as a transcript (NK4) that is selectively expressed in lymphocytes and NK cells and whose expression is increased following activation by IL-2 . It was later re-isolated from an IL-18-treated lung carcinoma cell line and re-named IL-32 (2). IL-32 is unusual in that it does not share sequence homology with known cytokine families and is highly expressed in immune tissues, existing in at least four differentially spliced isoforms. Because treatment of human monocytic and mouse macrophage cells with IL-32 induces several proinflammatory cytokines such as TNF-alpha, IL-8 and MIP-2, and because it is also induced in human peripheral lymphocyte cells after mitogen stimulation and in epithelial cells by IFNgamma, it has been suggested that IL-32 may play a role in autoimmune and inflammatory diseases such as rheumatoid arthritis (3).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IL-32 (CT), Interelukin 32&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C3749.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 118px; height: 167px;" src="http://www.biosyn.com/Images%5Cantibody%5C3749.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;                                         Left: Western blot analysis of  IL-32 in human spleen cell lysate with IL-32 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at (A) 5 and (B)  10 µg/ml shows two isoforms of IL-32. Below: Immunohistochemistry of  IL-32 in human spleen tissue with IL-32 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at 10 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IL-32 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a 15 amino acid &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; from near the carboxy terminus of human IL-32.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Affinity chromatography purified via &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IL-32 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Immunogen: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Human IL-32 (C-Terminus) Peptide (Cat. No. 3749P)&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IL-32 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for the detection of IL-32 by Western blot at 5 – 10 µg/ml.This antibody detects all isoforms of IL-32.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s):&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; E, WB, IHC&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat. No. 3749P - IL-32 Peptide&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IL-32 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. Cat. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;No. 1306 - Human Spleen Tissue Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; H, M&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;14424787&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;AAH09401&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; (CT) Interleukin 32&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;  1.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Dahl CA, Schall RP, He HL, et al. Identification of a novel gene expressed in activated natural killer cells and T cells. J. Immunol. 1992; 148:597-603.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;  &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt; 2.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Kim S-H, Han S-Y, Azam T, et al. Interleukin-32: a cytokine and inducer of TNF-a. Immunity 2005; 22:131-42.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;  3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Cagnard N, Letourneur F, Essabbani A, et al. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur. Cyto. Network 2005; 16:289-92.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-7552718546521411975?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/7552718546521411975/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=7552718546521411975' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7552718546521411975'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7552718546521411975'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/il-32-antibody.html' title='IL-32 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-3335607321185037252</id><published>2011-06-30T09:15:00.004-08:00</published><updated>2011-06-30T09:18:36.421-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IL-31 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;IL-31 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:3747&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells (1,2). IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor (2). In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways (3). RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells . IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development (1,4).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IL-31 (IN), Interleukin 31, IL31&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C3747.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 124px; height: 182px;" src="http://www.biosyn.com/Images%5Cantibody%5C3747.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of IL-31 in human skeletal muscle tissue lysate with IL-31 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at (A) 2.5, (B) 5 and (C) 10 µg/ml.                                                                              &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IL-31 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a 18 amino acid &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; from near the center of human IL-31.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Affinity chromatography purified via &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IL-31 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Immunogen: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Human IL-31 (Intermediate Domain) &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; (Cat. No. 3747P)&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;A&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;pplication:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IL-31 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for the detection of IL-31 by Western blot at 2.5 – 5 µg/ml.Despite its predicted size, IL-31 runs at approximately 27 - 30 kDa in SDS-PAGE.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s):&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; E, WB&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat. No. 3747P - IL-31 Peptide&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IL-31 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. Cat.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; No. 1375 - Human Skeletal Muscle Tissue Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;H, M&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; 46241139&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;AAS82846&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; (IN) Interleukin 31&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   1. Dillon SR, Sprecher C, Hammond A, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 2004; 5:752-60.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   2. Dreuw A, Radtke S, Pflanz S, et al. Characterization of the signaling capacities of the novel gp130-like cytokine receptor. J. Biol. Chem. 2004; 279:36112-20.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   3. Diveu C, Lak-Hal AH, Froger J, et al. Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling. Eur. Cytokine Netw. 2004; 15:291-302.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;   4. Bilsborough J, Leung DY, Maurer M, et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J. Allergy Clin. Immunol. 2006; 117:418-25.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-3335607321185037252?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/3335607321185037252/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=3335607321185037252' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/3335607321185037252'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/3335607321185037252'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/il-31-antibody_30.html' title='IL-31 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-104941816479034072</id><published>2011-06-30T09:10:00.004-08:00</published><updated>2011-06-30T09:14:48.186-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IL-31 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;IL-31 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:3745&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells (1,2). IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor (2). In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways (3). RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells . IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development (1,4).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IL-31 (NT), Interleukin 31, IL31&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C3745.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 139px; height: 184px;" src="http://www.biosyn.com/Images%5Cantibody%5C3745.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot analysis of IL-31 in RAW264.7 cell lysate with IL-31 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at (A) 2.5, (B) 5 and (C) 10 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunohistochemistry of IL-31 in rat skeletal muscle tissue with IL-31 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at 10 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_214.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 151px; height: 145px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_214.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IL-31 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; was raised against a 16 amino acid &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; from near the amino terminus of mouse IL-31.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification: &lt;/span&gt;Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone:&lt;/span&gt; This is a polyclonal &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host:&lt;/span&gt; IL-31 antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Immunogen: &lt;/span&gt;Murine IL-31 (N-Terminus) Peptide (Cat. No. 3745P)&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; IL-31 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be used for the detection of IL-31 by Western blot at 2.5 – 5 µg/ml.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s): &lt;/span&gt;E, WB, IHC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat. No. 3745P - IL-31 Peptide&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; IL-31 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. Cat. No. &lt;/span&gt;1283 - RAW264.7 Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;2. Cat. No. &lt;/span&gt;1467 - Rat Skeletal Muscle Tissue Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity:&lt;/span&gt; M&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number: &lt;/span&gt;46241139&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; AAS82846&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; (NT) Interleukin 31&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;   1. Dillon SR, Sprecher C, Hammond A, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 2004; 5:752-60.&lt;br /&gt;   2. Dreuw A, Radtke S, Pflanz S, et al. Characterization of the signaling capacities of the novel gp130-like cytokine receptor. J. Biol. Chem. 2004; 279:36112-20.&lt;br /&gt;   3. Diveu C, Lak-Hal AH, Froger J, et al. Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling. Eur. Cytokine Netw. 2004; 15:291-302.&lt;br /&gt;   4. Bilsborough J, Leung DY, Maurer M, et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J. Allergy Clin. Immunol. 2006; 117:418-25.&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-104941816479034072?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/104941816479034072/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=104941816479034072' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/104941816479034072'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/104941816479034072'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/il-31-antibody.html' title='IL-31 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-766083013076514760</id><published>2011-06-23T06:48:00.002-08:00</published><updated>2011-06-23T06:57:38.917-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='DNA strand'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='DNA Strands'/><category scheme='http://www.blogger.com/atom/ns#' term='DNA Strand Hypothesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>DNA Strand</title><content type='html'>&lt;div  style="text-align: center;font-family:verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/dna_strand.aspx"&gt;&lt;span style="font-weight: bold;"&gt;DNA Strand&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-family: verdana; font-weight: bold;" href="http://www.biosyn.com/"&gt;Bio-Synthesis&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; continued to provide quality DNA products and services for the research community, but it has also become a world leader in providing &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/"&gt;custom peptide&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; products and services. We offer comprehensive services for polyclonal antibody production with large selection for host animals.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;DNA Strand Hypothesis&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;The immortal DNA strand hypothesis was proposed in 1975 by John Cairns as a mechanism for adult stem cells to minimize mutations in their genomes. This hypothesis proposes that instead of segregating their DNA during mitosis in a random manner, adult stem cells divide their DNA asymmetrically, and retain a distinct template set of &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/DNAOverview.aspx"&gt;DNA&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; strands (parental strands) in each division. By retaining the same set of template DNA strands, adult stem cells would pass mutations arising from errors in DNA replication on to non-stem cell daughters that soon terminally differentiate (end mitotic divisions and become a functional cell).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;DNA Strands&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;In the label-retention assay, the goal is to mark 'immortal' or parental &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/"&gt;DNA strands&lt;/a&gt;&lt;span style="font-family:verdana;"&gt; with a DNA label such as tritiated thymidine or bromodeoxyuridine (BrdU). These types of DNA labels will incorporate into the newly-synthesized DNA of dividing cells during S phase. A pulse of DNA label is given to adult stem cells under conditions where they have not yet delineated an immortal DNA strand. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;For more information visit:&lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/"&gt; www.biosyn.com&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-766083013076514760?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/766083013076514760/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=766083013076514760' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/766083013076514760'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/766083013076514760'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/dna-strand.html' title='DNA Strand'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-82577390631683154</id><published>2011-06-23T06:42:00.002-08:00</published><updated>2011-06-23T06:47:13.805-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IL-17 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IL-17_Antibody-4017.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IL-17 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:4877&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Interleukin 17 (IL-17) is a family of pro-inflammatory cytokines produced by activated T cells and is thought to have a major role in the initiation and perpetuation of rheumatoid arthritis. IL-17 regulates the activities of NF-kB and mitogen-activated protein kinases such as ERK and JNK. In addition, IL-17 stimulates the expression of IL-6 and cyclooxygenase-2 and enhances the production of nitric oxide. IL-17-producing T helper cells (TH-17 cells) have been the subject of much attention due to the importance of IL-17 in the pathogenesis of autoimmune inflammation. Because of its role in autoimmune diseases, it is thought that targeting the production and action of IL-17 would be beneficial therapeutically in these diseases.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IL-17 (NT), Interleukin-17, IL-17A, CTLA8&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C4877.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 169px; height: 265px;" src="http://www.biosyn.com/Images%5Cantibody%5C4877.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt; Western blot analysis of IL-17 in A-20 lysate with IL-17 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at (A) 2 and (B) 4 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IL-17 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; was raised against a 16 amino acid &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; from near the amino terminus of human IL-17A.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification: &lt;/span&gt;Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone:&lt;/span&gt; This is a polyclonal &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host: &lt;/span&gt;IL-17 antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; IL-17 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be used for the detection of IL-17 by Western blot at 2 – 4 µg/ml.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s):&lt;/span&gt; E, WB&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat.No. 4877P - IL-17 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; IL-17 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control&lt;/span&gt;:&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. Cat. &lt;/span&gt;No. 1288 - A20 Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity: &lt;/span&gt;H, M&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number:&lt;/span&gt; 4504651&lt;br /&gt;Accession Number: NP_002181&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; (NT) Interleukin-17A&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   1. &lt;/span&gt;Miossec P. Are T cells in rheumatoid synovium aggressors or bystanders? Curr. Opin. Rheumatol. 2000; 12:181-5.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2. &lt;/span&gt;Paunovic V, Carroll HP, Vandenbroeck K, et al. Crossed signals: the role of interleukin (IL)-12, -17, -23, and -27 in autoimmunity. Rheumatol. 2008; 47:771-6.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   3. &lt;/span&gt;Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat. Med. 2007; 13:139-145.&lt;br /&gt;&lt;/span&gt;                                         &lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-82577390631683154?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/82577390631683154/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=82577390631683154' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/82577390631683154'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/82577390631683154'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/il-17-antibody_23.html' title='IL-17 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-4519518168143591725</id><published>2011-06-23T06:38:00.003-08:00</published><updated>2011-06-23T06:42:29.875-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IL-17 Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IL-17_Antibody-4005.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IL-17 Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:4887&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Interleukin 17 (IL-17) is a family of pro-inflammatory cytokines produced by activated T cells and is thought to have a major role in the initiation and perpetuation of rheumatoid arthritis. IL-17 regulates the activities of NF-kB and mitogen-activated protein kinases such as ERK and JNK. In addition, IL-17 stimulates the expression of IL-6 and cyclooxygenase-2 and enhances the production of nitric oxide. IL-17-producing T helper cells (TH-17 cells) have been the subject of much attention due to the importance of IL-17 in the pathogenesis of autoimmune inflammation. Because of its role in autoimmune diseases, it is thought that targeting the production and action of IL-17 would be beneficial therapeutically in these diseases.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong style="font-family: verdana;"&gt;Additional Names: &lt;/strong&gt;&lt;/span&gt;                            &lt;span style="font-size:100%;"&gt;&lt;span style="font-family: verdana;"&gt;IL-17 (IN), Interleukin-17, IL-17A, CTLA8&lt;/span&gt;&lt;br /&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C4887.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 169px; height: 270px;" src="http://www.biosyn.com/Images%5Cantibody%5C4887.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of IL-17 in A-20 lysate with IL-17 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at (A) 0.5 and (B) 1 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IL-17 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a 19 amino acid &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; from near the center of human IL-17A.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Affinity chromatography purified via &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IL-17 antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IL-17 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for the detection of IL-17 by Western blot at 0.5 – 1 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s)&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;: E, WB&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;:Cat.No. 4887P - IL-17 &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IL-17 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1.Cat. No. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;1288 - A20 Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; H, M&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; 4504651&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; NP_002181&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; (IN) Interleukin-17A&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   1. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Miossec P. Are T cells in rheumatoid synovium aggressors or bystanders? Curr. Opin. Rheumatol. 2000; 12:181-5.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   2. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Paunovic V, Carroll HP, Vandenbroeck K, et al. Crossed signals: the role of interleukin (IL)-12, -17, -23, and -27 in autoimmunity. Rheumatol. 2008; 47:771-6.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat. Med. 2007; 13:139-145.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;                                         &lt;div style="font-family: verdana;" class="npdet_box2"&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-4519518168143591725?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/4519518168143591725/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=4519518168143591725' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4519518168143591725'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4519518168143591725'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/il-17-antibody.html' title='IL-17 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-8927211668797784692</id><published>2011-06-23T06:31:00.004-08:00</published><updated>2011-06-23T06:36:37.665-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IKK gamma Antibody</title><content type='html'>&lt;span style="font-size:100%;"&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5Cd_378.gif"&gt;&lt;br /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IKK_gamma_Antibody-4338.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IKK gamma Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:2335&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Nuclear factor kappa B (NF-kappaB) is a ubiquitous transcription factor and an essential mediator of gene expression during activation of immune and inflammatory responses. NF-kappaB mediates the expression of a great variety of genes in response to extracellular stimuli. NF-kappaB is associated with IkB proteins in the cell cytoplasm, which inhibit NF-kappaB activity. The IkB kinase (IKKalpha and IKKbeta) phosphorylates IkB and mediates NF-kappaB activation. A novel molecule in the IKK complex was recently identified and termed IKKgamma/NEMO/FIP3/IKKAP1 (1-5). IKKg interacts with IKKbeta and is required for the activation of IKK complex and NF-kappaB by LPS, PMA, TNF, and IL-1 stimulation (1-4). FIP3 was also shown to bind to RIP and NIK and to mediate TNF-induced NF-kappaB activation (3).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IKK gamma (CT),IKKg / NEMO, NEMO, FIP3&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C2335.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 85px; height: 163px;" src="http://www.biosyn.com/Images%5Cantibody%5C2335.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;/span&gt;                                       &lt;span style="font-size:100%;"&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of IKK gamma in HeLa whole cell lysate with IKK gamma &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at 1 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Below:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Immunocytochemistry of IKK gamma in HeLa cells with IKK gamma &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at 5 µg/ml.                                                                                &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Other Product Images&lt;/b&gt;&lt;/span&gt;                                                                            &lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5Cd_378.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 172px; height: 144px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_378.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                     &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IKK gamma &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; corresponding to amino acids 400 to 416 of human IKK gamma, which are identical to those of mouse homologue.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Affinity chromatography purified via &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;IKK gamma antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Immunogen:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Human IKK gamma Peptide (Cat. No. 2335P)&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IKK gamma &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be used for detection of IKK gamma by Western blot at 0.5 to 1 µg/ml.A 52 kDa band should be detected. IKK gamma has no cross response to IKK alpha or IKK beta.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s):&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; E, WB, ICC&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;Antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat. No. 2335P - IKK gamma &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; IKK gamma antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1.Cat. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;No. 1201 - HeLa Cell Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;H, M, R&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; 3641279&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; AF074382&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; (CT) IkB Kinase gamma&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;  1.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Rothwarf DM, Zandi E, Natoli G, Karin M. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 1998;395(6699):297-300&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   2. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ, Israel A. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 1998;93(7):1231-40.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;  &lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt; 3.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Li Y, Kang J, Friedman J, Tarassishin L, Ye J, Kovalenko A, Wallach D, Horwitz MS. Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. Proc Natl Acad Sci U S A 1999;96(3):1042-7&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   4.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Mercurio F, Murray BW, Shevchenko A, Bennett BL, Young DB, Li JW, Pascual G, Motiwala A, Zhu H, Mann M, Manning AM. IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol Cell Biol. 1999;19(2):1526-38.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-8927211668797784692?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/8927211668797784692/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=8927211668797784692' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/8927211668797784692'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/8927211668797784692'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/ikk-gamma-antibody.html' title='IKK gamma Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-1986972371391682661</id><published>2011-06-22T08:12:00.004-08:00</published><updated>2011-06-22T08:21:21.676-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='antibodies'/><category scheme='http://www.blogger.com/atom/ns#' term='Clone Antibody'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Antibody Production'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Isotypes'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>Clone Antibody</title><content type='html'>&lt;span style=";font-family:verdana;font-size:100%;"  &gt;&lt;br /&gt;&lt;/span&gt;&lt;div  style="text-align: center;font-family:verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/clone_antibody.aspx"&gt;&lt;span style="font-weight: bold;"&gt;Clone Antibody&lt;/span&gt; &lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style=";font-family:verdana;font-size:100%;"  &gt;&lt;br /&gt;Bio-Synthesis, with 20 years of experience in developing polyclonal &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibodies&lt;/a&gt;, is a leading global provider of &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;custom antibody&lt;/a&gt; production services. Our facility generates high-affinity custom antibodies with industry-leading titer guarantees and comprehensive antibody production packages that simplify the ordering process and present cost-effective methods to isolate epitope-specific antibodies. Visit &lt;a style="font-weight: bold;" href="http://www.biosyn.com/"&gt;www.biosyn.com&lt;/a&gt; and see why partner with Bio-Synthesis for your custom antibodies needs.&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-weight: bold;font-family:verdana;font-size:100%;"  &gt;Antibodies&lt;/span&gt;&lt;span style=";font-family:verdana;font-size:100%;"  &gt;&lt;br /&gt;&lt;br /&gt;From Antigen selection to antibody purification, BSI has optimized each step of the antibody production process to provide the best &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibodies&lt;/a&gt; available.&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-weight: bold;font-family:verdana;font-size:100%;"  &gt;Custom peptide antibody production&lt;/span&gt;&lt;span style=";font-family:verdana;font-size:100%;"  &gt;&lt;br /&gt;&lt;br /&gt;Keyhole Limpet Hemocyanin (KLH), Bovine Serum Albumin (BSA), Rabbit Serum Albumin (RSA), Ovalbumin, Thyroglobulin, or Human Gamma Globulin (HGG).Amino Acid Analysis of Conjugates also available.&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-weight: bold;font-family:verdana;font-size:100%;"  &gt;Isotypes&lt;/span&gt;&lt;span style=";font-family:verdana;font-size:100%;"  &gt;&lt;br /&gt;&lt;br /&gt;&lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;Antibodies&lt;/a&gt; can come in different varieties known as isotypes or classes. In placental mammals there are five antibody isotypes known as IgA, IgD, IgE,IgG and IgM.The antibody isotype of a B cell changes during the cell's development and activation.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.biosyn.com/landingpage/images/LandingPage_mainimage.jpg"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 349px; height: 127px;" src="http://www.biosyn.com/landingpage/images/LandingPage_mainimage.jpg" alt="" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;For more information visit: &lt;a style="font-weight: bold;" href="http://www.biosyn.com/"&gt;www.biosyn.com&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-1986972371391682661?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/1986972371391682661/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=1986972371391682661' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/1986972371391682661'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/1986972371391682661'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/clone-antibody.html' title='Clone Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-658677534455619724</id><published>2011-06-22T08:04:00.004-08:00</published><updated>2011-06-22T08:11:38.202-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IKK epsilon Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IKK_epsilon_Antibody-4337.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IKK epsilon Antibody&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:2329&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Nuclear factor kappa B (NF-kappaB) is a ubiquitous transcription factor and an essential mediator of gene expression during activation of immune and inflammatory responses. NF-kappaB mediates the expression of a great variety of genes in response to extracellular stimuli. NF-kappaB is associated with IkB proteins in the cell cytoplasm, which inhibit NF-kappaB activity. IkB is phosphorylated by IkB kinase (IKK) complex that contains IKKalpha, IKKbeta, and IKKgamma. A novel molecule in the IKK complex was recently identified and designated IKKepsilon/IKK-i (1,2). IKK epsilon is required for the activation of NF-kappaB by PMA and T cell receptors but not by TNFalpha and IL-1 (1). IKKepsilon/IKK-i message is expressed in a variety of tissues and is inducible by TNFalpha, IL-1, and LPS (2).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IKK epsilon (CT), IKKi, IKKe&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C2329.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 95px; height: 160px;" src="http://www.biosyn.com/Images%5Cantibody%5C2329.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot analysis of IKK epsilon in Jurkat whole cell lysate with IKK epsilon/IKK-i &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at 1 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunohistochemistry of IKK epsilon in human pancreas tissue with IKK epsilon &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at 10 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_53.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 240px; height: 190px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_53.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IKK epsilon &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; was raised against a &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; corresponding to amino acids 701 to 716 of human IKK epsilon/IKK-i.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification: &lt;/span&gt;Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone:&lt;/span&gt; This is a polyclonal &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host:&lt;/span&gt; IKK epsilon antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Immunogen&lt;/span&gt;: Human IKK epsilon Peptide (Cat. No. 2329P)&lt;br /&gt;Application: IKK epsilon &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be used for detection of IKK epsilon by Western blot at 0.5 to 1 µg/ml.An 80 kDa band should be detected. It has no cross response to IKKa, IKKb, or IKKy.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s): &lt;/span&gt;E, WB, IHC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat. No. 2329P - IKK epsilon &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; IKK epsilon &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1.&lt;/span&gt; Cat. No. 1205 - Jurkat Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;2.&lt;/span&gt; Cat. No. 1307 - Human Pancreas Tissue Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity: &lt;/span&gt;H&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number: &lt;/span&gt;7288877&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; AF241789&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; (CT) IkB Kinase epsilon&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   1.&lt;/span&gt; Peters RT, Liao SM, Maniatis T. IKK epsilonpsilon is part of a novel PMA-inducible IkappaB kinase complex. Mol Cell 2000;5(3):513-22&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2.&lt;/span&gt; Shimada T, Kawai T, Takeda K, Matsumoto M, Inoue J, Tatsumi Y, Kanamaru A, Akira S. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int Immunol 1999;11(8):1357-62 (WD010&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-658677534455619724?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/658677534455619724/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=658677534455619724' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/658677534455619724'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/658677534455619724'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/ikk-epsilon-antibody.html' title='IKK epsilon Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-5835443509562820351</id><published>2011-06-22T07:57:00.004-08:00</published><updated>2011-06-22T08:02:22.014-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IKK beta Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IKK_beta_Antibody-4770.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IKK beta Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:2121&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Nuclear factor kappa B (NF-kappaB) is a ubiquitous transcription factor and an essential mediator of gene expression during activation of immune and inflammatory responses. NF-kappaB mediates the expression of a great variety of genes in response to extracellular stimuli including IL-1, TNFalpha, and bacteria product LPS. NF-kappaB is associated with IkappaB proteins in the cell cytoplasm, which inhibit NF-kappaB activity. The long-sought IkappaB kinase (IKK), which phosphorylates IkappaB, and mediates IkappaB degradation and NF-kappaB activation, was recently identified by several laboratories (1-5). IKK is a serine protein kinase, and the IKK complex contains alpha and beta subunits (IKKalpha and IKKbeta). IKKalpha and IKKbeta interact with each other and both are essential for NF-kappaB activation. IKKbeta phosphorylates both IkappaB-alpha and IkappaB-beta. IKKbeta is expressed in variety of human tissues.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IKK beta (C3), IKK beta, I-kappa-B-kinase beta, I-kappa-B-kinase 2&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C2121.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 105px; height: 169px;" src="http://www.biosyn.com/Images%5Cantibody%5C2121.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot analysis of IKK beta in Jurkat whole cell lysate with IKK beta &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; (C3) at 1:500 dilution.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunocytochemistry staining of HeLa cells using IKK beta &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at 10 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_43.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 228px; height: 250px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_43.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IKK beta &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; was raised against a &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; corresponding to amino acids near the carboxy-terminus of human IKK beta (Genbank accession NoO14920), which differs from corresponding murine sequence by one amino acid.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification:&lt;/span&gt; Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone:&lt;/span&gt; This is a polyclonal antibody.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host: &lt;/span&gt;IKK beta antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Immunogen&lt;/span&gt;: Human IKK beta (C-Terminus 3) &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt; (Cat. No. 2121P)&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; IKK beta &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be used for detection of IKK beta by Western blot at 1 – 2 µg/ml.A 87 kDa band should be detected. This polyclonal antibody has no cross response to IKKa or IKKy.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s):&lt;/span&gt; E, WB, ICC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer:&lt;/span&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat. No. 2121P - IKK beta Peptide&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; IKK beta &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1.&lt;/span&gt; Cat. No. 1205 - Jurkat Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;2. &lt;/span&gt;Cat. No. 1201 - HeLa Whole Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity:&lt;/span&gt; H&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number: &lt;/span&gt;14285497&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number: &lt;/span&gt;O14920&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; (C3) Ikappa B kinase beta&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   1. &lt;/span&gt;DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997;388:548-54&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2.&lt;/span&gt; Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. Identification and characterization of an IkappaB kinase. Cell 1997;90:373-83&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   3.&lt;/span&gt; Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997;91:243-52&lt;br /&gt; &lt;span style="font-weight: bold;"&gt;  4. &lt;/span&gt;Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DY. IkappaB kinase-alpha: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 1997;278:866-9&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-5835443509562820351?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/5835443509562820351/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=5835443509562820351' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5835443509562820351'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5835443509562820351'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/ikk-beta-antibody.html' title='IKK beta Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-7955764000654005641</id><published>2011-06-22T07:45:00.004-08:00</published><updated>2011-06-22T07:56:41.351-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IKK alpha Antibody</title><content type='html'>&lt;div  style="text-align: center;font-family:verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IKK_alpha_Antibody-4769.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IKK alpha Antibody&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold;font-family:verdana;" &gt;:2117&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;Nuclear factor kappa B (NF-kappaB) is a ubiquitous transcription factor and an essential mediator of gene expression during activation of immune and inflammatory responses. NF-kappaB mediates the expression of a great variety of genes in response to extracellular stimuli including IL-1, TNFalpha and bacteria product LPS. NF-kappaB is associated with IkB proteins in the cell cytoplasm, which inhibit NF-kappaB activity. The long-sought IΚB kinase (IKK), which phosphorylates IkappaB, and mediates IkappaB degradation and NF-kappaB activation, was recently identified by several laboratories (1-5). IKK is a serine protein kinase, and the IKK complex contains alpha and beta subunits (IKKalpha and IKKΒ). IKKalpha and IKKbeta interact with each other and both are essential for the NF-kappaB activation. IKKalpha specifically phosphorylates IkappaB-alpha. IKKalpha is expressed in a variety of human tissues.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div  class="npdet_box2" style="font-family:verdana;"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IKK alpha (C3), IKK-1, IKKa&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C2117.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 112px; height: 187px;" src="http://www.biosyn.com/Images%5Cantibody%5C2117.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot analysis of IKK alpha in Jurkat whole cell lysate with IKK alpha antibody (C3) at 1:500 dilution.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunocytochemistry of IKK alpha in Jurkat cells with IKK alpha &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at 10 µg/ml.                                                                               &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_278.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 171px; height: 132px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_278.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IKK alpha&lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt; antibody&lt;/a&gt; was raised against a &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; corresponding to amino acids 658 to 674 of human IKK alpha, which differs from corresponding murine sequence by one amino acid.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification:&lt;/span&gt; Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone: &lt;/span&gt;This is a polyclonal &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host:&lt;/span&gt; IKK alpha antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Immunogen:&lt;/span&gt; Human IKK alpha (C-Terminus 3) Peptide (Cat. No. 2117P)&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; IKK alpha &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be used for detection of IKK alpha by Western blot at 1:500 to 1:1000 dilution. An 85 kDa band should be detected. This polyclonal antibody has no cross response to IKKb or IKKy.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s):&lt;/span&gt; E, WB, ICC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer:&lt;/span&gt; Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat. No. 2117P - IKK alpha &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; IKK alpha &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1.&lt;/span&gt; Cat. No. 1205 - Jurkat Cell Lysate&lt;br /&gt;Species Reactivity: H&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number:&lt;/span&gt; 2327068&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number: &lt;/span&gt;AF009225&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description: &lt;/span&gt;(C3) Ikappa B kinase alpha&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   1. &lt;/span&gt;DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997;388:548-54&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2. &lt;/span&gt;Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. Identification and characterization of an IkappaB kinase. Cell 1997;90:373-83&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   3.&lt;/span&gt; Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997;91:243-52&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;  4. &lt;/span&gt;Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DY. IkappaB kinase-alpha: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 1997;278:866-9&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-7955764000654005641?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/7955764000654005641/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=7955764000654005641' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7955764000654005641'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7955764000654005641'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/ikk-alpha-antibody_22.html' title='IKK alpha Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-7892257649933077096</id><published>2011-06-21T07:52:00.001-08:00</published><updated>2011-06-21T08:02:03.904-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='DNA Familial Relationship Tests'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='DNA Test For Free'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='DNA-Binding Proteins'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>DNA Test For Free</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/dna_test_for_free.aspx"&gt;&lt;span style="font-weight: bold;"&gt;DNA Test For Free&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;At &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;Biosynthesis&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; DNA Diagnostics is a multi-species molecular genetics laboratory specializing in human and animal DNA testing for individuals, law enforcement, attorneys, breed associations, private investigators and state regulatory agencies.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;DNA Familial Relationship Tests &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;DNA testing&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can definitively identify distant biological relationships. Our laboratory routinely performs DNA tests in cases of questioned grandparent age, siblingship, twin zygosity, maternity and more.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;DNA Identification and Verification &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;The &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/DNAOverview.aspx"&gt;DNA Identity Testing Center &lt;/a&gt;&lt;span style="font-family: verdana;"&gt;also provides genetic profiling via our SAFEDNATM ID card. Your SAFEDNA ID card will provide positive identification and may be used to ensure child safety, prevent fraud and protect asset.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;DNA-Binding Proteins&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Structural proteins that bind DNA are well-understood examples of non-specific DNA-protein interactions. Within chromosomes, &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/DNAOverview.aspx"&gt;DNA&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; is held in complexes with structural proteins. These proteins organize the DNA into a compact structure called chromatin.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;For more information visit:&lt;/span&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com"&gt;&lt;span style="font-weight: bold;"&gt; www.biosyn.com&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-7892257649933077096?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/7892257649933077096/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=7892257649933077096' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7892257649933077096'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/7892257649933077096'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/dna-test-for-free.html' title='DNA Test For Free'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-6238964779633786666</id><published>2011-06-21T07:47:00.004-08:00</published><updated>2011-06-21T07:51:28.235-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IKK alpha Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IKK_alpha_Antibody-4768.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IKK alpha Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:2115&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Nuclear factor kappa B (NF-kappaB) is a ubiquitous transcription factor and an essential mediator of gene expression during activation of immune and inflammatory responses. NF-kappaB mediates the expression of a great variety of genes in response to extracellular stimuli including IL-1, TNFalpha and bacteria product LPS. NF-kappaB is associated with IkB proteins in the cell cytoplasm, which inhibit NF-kappaB activity. The long-sought IkappaB kinase (IKK), which phosphorylates IkappaB, and mediates IkappaB degradation and NF-kappaB activation, was recently identified by several laboratories (1-5). IKK is a serine protein kinase, and the IKK complex contains alpha and beta subunits (IKKalpha and IKKΒ). IKKalpha and IKKb interact with each other and both are essential for the NF-kappaB activation. IKKalpha specifically phosphorylates IkappaB-Α.IKKalpha is expressed in a variety of human tissues.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IKK  alpha (C2), Inhibitor of nuclear factor kappa-B kinase alpha subunit,  IkappaB kinase alpha, NFkappaB inhibitor kinase alpha, IKKa&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C2115.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 95px; height: 181px;" src="http://www.biosyn.com/Images%5Cantibody%5C2115.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot analysis of IKK alpha in HeLa whole cell lysate with IKK alpha &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at 1:500 dilution.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunocytochemistry of IKK alpha in HeLa cells with IKK alpha antibody at 10 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_253.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 172px; height: 136px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_253.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IKK alpha &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; was raised against a &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; corresponding to amino acids 699 to 715 of human IKK alpha, which differs from corresponding murine sequence by one amino acid&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification: &lt;/span&gt;Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone: &lt;/span&gt;This is a polyclonal &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host:&lt;/span&gt; IKK alpha antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Immunogen:&lt;/span&gt; Human IKK alpha (C-Terminus 2) Peptide (Cat. No. 2115P)&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; IKK alpha antibody can be used for detection of IKK alpha by Western blot at 1:500 to 1:1000 dilution. A 85 kDa band should be detected. This polyclonal &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; has no cross response to IKKb or IKKy.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s):&lt;/span&gt; E, WB, ICC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat. No. 2115P - IKK alpha &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; IKK alpha &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1.&lt;/span&gt; Cat. No. 1201 - HeLa Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity:&lt;/span&gt; H&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number:&lt;/span&gt; 2327068&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number: &lt;/span&gt;AF009225&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; (C2) Ikappa B kinase alpha&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   1.&lt;/span&gt; DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997;388:548-54&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2.&lt;/span&gt; Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. Identification and characterization of an IkappaB kinase. Cell 1997;90:373-83&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   3.&lt;/span&gt; Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKalpha, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997;91:243-52&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   4. &lt;/span&gt;Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DY. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 1997;278:866-9&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-6238964779633786666?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/6238964779633786666/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=6238964779633786666' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/6238964779633786666'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/6238964779633786666'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/ikk-alpha-antibody_21.html' title='IKK alpha Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-5502626254328358231</id><published>2011-06-21T07:42:00.003-08:00</published><updated>2011-06-21T07:47:40.396-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IKK alpha Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IKK_alpha_Antibody-4753.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IKK alpha Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:2025&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Nuclear factor kappa B (NF-kappaB) is a ubiquitous transcription factor and an essential mediator of gene expression during activation of immune and inflammatory responses. NF-kappaB mediates the expression of a great variety of genes in response to extracellular stimuli including IL-1, TNFa, and bacteria product LPS. NF-kappaB is associated with IkappaB proteins in the cell cytoplasm, which inhibit NF-kappaB activity. The long-sought IkappaB kinase (IKK), which phosphorylates IkappaB, and mediates IΚB degradation and NF-kappaB activation, was recently identified by several laboratories (1-5). IKK is a serine protein kinase, and the IKK complex contains alpha and beta subunits (IKKalpha and IKKbeta). IKKa and IKKbeta interact with each other and both are essential for the NF-kappaB activation. IKKalpha specifically phosphorylates IkB-alpha. IKKalpha is expressed in variety of human tissues.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IKK alpha (C1), IKKa, IKK-1&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C2025.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 96px; height: 171px;" src="http://www.biosyn.com/Images%5Cantibody%5C2025.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot analysis of IKK alpha in HeLa whole cell lysate with IKK alpha &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;antibody&lt;/a&gt; at 1:1000 dilution.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunocytochemistry of IKK alpha in Jurkat cells with IKK alpha &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;antibody&lt;/a&gt; at 1µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_276.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 168px; height: 127px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_276.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IKK alpha &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;antibody&lt;/a&gt; was raised against a &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; corresponding to amino acids 716 to 734 of human IKK alpha, which differs from corresponding murine sequence by four amino acids.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification:&lt;/span&gt; Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone:&lt;/span&gt; This is a polyclonal &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;antibody&lt;/a&gt;.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host: &lt;/span&gt;IKK alpha antibody was raised in rabbit.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Immunogen:&lt;/span&gt; Human IKK alpha (C-Terminus 1) &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt; (Cat. No. 2025P)&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; IKK alpha can be used for detection of IKK alpha by Western blot at 1:1000 to 1:2000 dilution. An 85 kDa band should be detected. &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;antibody&lt;/a&gt; has no cross response to IKKb or IKKg.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s):&lt;/span&gt; E, WB, ICC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat. No. 2025P - IKK alpha &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage:&lt;/span&gt; IKK alpha antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1.&lt;/span&gt; Cat. No. 1201 - HeLa Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;2.&lt;/span&gt; Cat. No. 1205 Jurkat Whole Cell Lysate&lt;br /&gt;Species Reactivity: H&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number:&lt;/span&gt; 2327068&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; AF009225&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; (C1) Ikappa B kinase alpha&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt; &lt;span style="font-weight: bold;"&gt;  1. &lt;/span&gt;DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997;388:548-54&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2. &lt;/span&gt;Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. Identification and characterization of an IkappaB kinase. Cell 1997;90:373-83&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   3. &lt;/span&gt;Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997;91:243-52&lt;br /&gt; &lt;span style="font-weight: bold;"&gt;  4. &lt;/span&gt;Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DY. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 1997;278:866-9&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-5502626254328358231?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/5502626254328358231/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=5502626254328358231' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5502626254328358231'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5502626254328358231'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/ikk-alpha-antibody.html' title='IKK alpha Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-4425028168791756173</id><published>2011-06-21T07:35:00.004-08:00</published><updated>2011-06-21T07:41:33.599-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>IKAP Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/IKAP_Antibody-4339.aspx"&gt;&lt;span style="font-weight: bold;"&gt;IKAP Antibody&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt; &lt;/div&gt; &lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;#:2337&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;IKAP was initially identified as a scaffold protein of the IkappaB kinase complex that could bind to IKKalpha, IKKbeta, NF-kappaB, and the NF-kappaB-inducing kinase (NIK), although later evidence has cast doubt on this. More recent reports show that mutations in IKAP such as a frameshift leading to a truncated protein or a missense mutation that leads to defective phosphorylation are responsible for the autosomal recessive genetic disease familial dysautonomia (FD). Reports indicating that it forms part of the RNA polymerase II transcription elongation complex suggest that this disease may be due to compromised transcription elongation. More recently, it was shown that IKAP associates with c-Jun N-terminal kinase (JNK) and could specifically enhance JNK activation induced by the upstream JNK activators MEKK1 and ASK1, indicating another possible cause for FD. At least two isoforms of IKAP are known two exist.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;IKAP, IKK complex-associated protein, IKBKAP&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C2337.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 164px; height: 175px;" src="http://www.biosyn.com/Images%5Cantibody%5C2337.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;&lt;/span&gt;                                        &lt;span style="font-size:100%;"&gt; Western blot analysis of IKAP in A-20 cell lysate with IKAP antibody at in (A) 0.5, and (B) 1 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunocytochemistry of IKAP in A-20 cells with IKAP antibody at 1 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Images&lt;br /&gt;&lt;/b&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_468.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 169px; height: 142px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_468.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;IKAP antibody was raised against a 16 amino acid &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; from near the carboxy terminus of human IKAP.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Purification: &lt;/span&gt;Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone:&lt;/span&gt; This is a polyclonal &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host:&lt;/span&gt; IKAP antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; IKAP antibody can be used for detection of IKAP by Western blot at 0.5 to 1 µg/ml.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s):&lt;/span&gt; E, WB, ICC&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;&lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;Antibody&lt;/a&gt; is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat.No. 2337P - IKAP &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage: &lt;/span&gt;IKAP antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;Antibodies&lt;/a&gt; should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. Cat&lt;/span&gt;. No. 1288 - A20 Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity: &lt;/span&gt;H, M&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number:&lt;/span&gt; 3757822&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; AAC64258&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; part of the RNA polymerase II transcription elongation complex&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   1.&lt;/span&gt; Cohen L, Henzel WJ, and Baeuerle PA. IKAP is a scaffold protein of the IkB kinase complex. Nature 1998; 395:292-6.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2.&lt;/span&gt; Krappmann D, Hatada EN, Tegethoff S, et al. The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component. J. Biol. Chem. 2000; 275:29779-87.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   3.&lt;/span&gt; Anderson SL, Coli R, Daly IW, et al. Familial dysautonomia is caused by mutations of the IKAP gene. Am. J. Hum. Genet. 2001; 68:753-8.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   4. &lt;/span&gt;Hawkes NA, Otero G, Winkler GS, et al. Purification and characterization of the human elongator complex. J. Biol. Chem. 2002; 277:3047-52.&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-4425028168791756173?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/4425028168791756173/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=4425028168791756173' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4425028168791756173'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4425028168791756173'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/ikap-antibody.html' title='IKAP Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-8014028702902471045</id><published>2011-06-20T08:33:00.001-08:00</published><updated>2011-06-20T08:35:29.980-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Amino Acid'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Amino Acid Serum'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Amino acids and DNA'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>Amino Acid Serum</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/landingpage/amino_acid_serum.aspx"&gt;&lt;span style="font-weight: bold;"&gt;Amino Acid Serum&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Bio-Synthesis, with 20 years of experience in developing polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/"&gt;antibodies&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;, is a leading global provider of &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/"&gt;custom antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; production services. Our facility generates high-affinity custom antibodies with industry-leading titer guarantees and comprehensive antibody production packages that simplify the ordering process and present cost-effective methods to isolate epitope-specific antibodies. Visit &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/"&gt;www.biosyn.com&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; and see why partner with Bio-Synthesis for your custom antibodies needs.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Amino Acid&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;In chemistry, an amino acid is a molecule containing both amine and carboxyl functional groups. In biochemistry, this term refers to alpha-amino acids with the general formula H2NCHRCOOH, where R is an organic subsistent. In the alpha amino acids, the amino and carboxylate groups are attached to the same carbon, which is called the α–carbon. The various alpha amino acids differ in which side chain (R group) is attached to their alpha carbon.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;An Essential Amino Acid&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;An essential amino acid or indispensable amino acid is an amino acid that cannot be synthesized de novo by the organism and therefore must be supplied in the diet.Nine amino acids are generally regarded as essential for humans: phenylalanine, valine, threonine, tryptophan, isoleucine, methionine, histidine, leucine, and lysine. Arginine is required by infants and growing kids. They are called essential not because they are more important to life than the others, but because the body does not&lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt; synthesize&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; them, making it essential to include them in one's diet in order to obtain them.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt; &lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Amino acids and DNA&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;DNA is a sequence of nucleotides. There are four nucleotides: adenine, thymine, cytosine, guanine. The exact sequence of these determines the code of each gene. When &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;DNA&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; is transcribed (the first step in expression of the gene), RNA is synthesized using this code. The RNA is a complementary copy of one strand of the DNA. The RNA leaves the nucleus and in the cytoplasm it is translated into a protein.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;For more information visit: &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com"&gt;www.biosyn.com&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-8014028702902471045?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/8014028702902471045/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=8014028702902471045' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/8014028702902471045'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/8014028702902471045'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/amino-acid-serum.html' title='Amino Acid Serum'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-5334590314598368458</id><published>2011-06-20T07:54:00.003-08:00</published><updated>2011-06-20T07:58:02.089-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>Hrk Antibody</title><content type='html'>&lt;div style="text-align: center; font-family: verdana;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/Hrk_Antibody-4061.aspx"&gt;&lt;span style="font-weight: bold;"&gt;Hrk Antibody&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;:3771&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Hrk, a pro-apoptotic member of the Bcl-2 homology domain-3 (BH3)-only group of the Bcl-2 family of proteins, was also identified as novel protein induced during programmed neuronal death. It lacks significant homology to other Bcl-2 family members except for an 8-amino acid region that is similar to the BH3 motif of Bik. Hrk regulates apoptosis through interaction with the anti-apoptotic proteins Bcl-2 and Bcl-XL via this domain. It does not interact with the pro-apoptotic proteins Bax, Bak, or Bcl-XS. Hrk localizes to mitochondrial membranes in a pattern similar to that previously reported for Bcl-2 and Bcl-XL. Despite its predicted molecular weight, Hrk often migrates at 12-15 kDa.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: verdana;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;Hrk, Harakiri, Neuronal death proteinDP&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a style="font-family: verdana;" href="http://www.biosyn.com/Images%5Cantibody%5C3771.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 121px; height: 187px;" src="http://www.biosyn.com/Images%5Cantibody%5C3771.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b style="font-family: verdana;"&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b style="font-family: verdana;"&gt;Left:&lt;/b&gt;&lt;span style="font-family: verdana;"&gt; Western blot analysis of Hrk in mouse pancreas tissue lysate with Hrk &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; at (A) 2.5 and (B) 5 µg/ml.                                                                              &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Source:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;HRK &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; was raised against a 15 amino acid &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; from near the center of human Hrk.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Purification&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;: Affinity chromatography purified via peptide column&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Clonality and Clone:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; This is a polyclonal &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Host:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Hrk antibody was raised in rabbit.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-family: verdana;"&gt;Please use anti-rabbit secondary antibodies.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Application: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Hrk antibody can be used for the detection of Hrk by Western blot at 2.5 - 5 µg/ml.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Tested Application(s):&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; E, WB&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Buffer&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;: Antibody is supplied in PBS containing 0.02% sodium azide.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Blocking Peptide:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Cat.No. 3771P - Hrk Peptide&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Long-Term Storage:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Hrk &lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt;&lt;span style="font-family: verdana;"&gt; can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;1. Cat. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;No. 1414 - Mouse Pancreas Tissue Lysate&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Species Reactivity: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;H, M&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;GI Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; 4504493&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Accession Number:&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; NP_003797&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;Short Description: &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;a Bcl-2 family member involved durring programmed neuronal death&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   1. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Lockshin RA, Osborne B, and Zakeri Z. Cell death in the third millennium. Cell Death Differ. 2000; 7:2-7.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   2.&lt;/span&gt;&lt;span style="font-family: verdana;"&gt; Imaizumi K, Tsuda M, Imai Y, et al. Molecular cloning of a novel poly&lt;/span&gt;&lt;a style="font-weight: bold; font-family: verdana;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt;&lt;span style="font-family: verdana;"&gt;, DP5, induced during programmed neuronal death. J. Biol. Chem. 1997; 272:18842-8.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold; font-family: verdana;"&gt;   3. &lt;/span&gt;&lt;span style="font-family: verdana;"&gt;Inohara N, Ding L, Chen S, et al. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-XL. EMBO J. 1997; 16:1686-94.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-5334590314598368458?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/5334590314598368458/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=5334590314598368458' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5334590314598368458'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/5334590314598368458'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/hrk-antibody.html' title='Hrk Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-4615537482741340361</id><published>2011-06-20T07:51:00.002-08:00</published><updated>2011-06-20T07:54:23.065-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>GDF6 Antibody</title><content type='html'>&lt;div style="text-align: center; font-weight: bold; font-family: trebuchet ms;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/GDF6_Antibody-4677.aspx"&gt;GDF6 Antibody&lt;br /&gt;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-family: trebuchet ms;"&gt;Catalog#&lt;/span&gt;&lt;span style="font-weight: bold; font-family: trebuchet ms;"&gt;:4691&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family: trebuchet ms;"&gt;Growth differentiation factors (GDFs) are members of the transforming growth factor (TGF) superfamily that is involved in embryonic development and adult tissue homeostasis. Both GDF6 and GDF7 are closely related to GDF5 which has been shown to induce activation of plasminogen activator, thereby inducing angiogenesis. It is predominantly expressed in long bones during fetal embryonic development and is involved in bone formation. In Xenopus, GDF6 is expressed at the edge of the neural plate and within the anterior neural plate including the eye fields. GDF6 is required for normal formation of some bones and joints in the limbs, skull, and axial skeleton. It may regulate patterning of the ectoderm by interacting with bone morphogenetic proteins (BMPs), and control eye development. Mutations in this gene result in colobomata, which are congenital abnormalities in ocular development, and in Klippel-Feil syndrome (KFS), a congenital disorder of spinal segmentation.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="font-family: trebuchet ms;" class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;GDF6 (CT), Growth Differentiation Factor 6, GDF16, GDF-6, CDMP2&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C4691.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 169px; height: 285px;" src="http://www.biosyn.com/Images%5Cantibody%5C4691.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt; Western blot analysis of GDF6 in SK-N-SH lysate with GDF6 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; at (A) 0.5 and (B) 1 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;GDF6 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;antibody&lt;/a&gt; was raised against a 17 amino acid &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; near the carboxy terminus of the human GDF6.&lt;br /&gt;Purification: Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone:&lt;/span&gt; This is a polyclonal antibody.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host:&lt;/span&gt; GDF6 antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary antibodies&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application:&lt;/span&gt; GDF6 antibody can be used for detection of GDF6 by Western blot at 1 µg/ml.&lt;br /&gt;Tested Application(s): E, WB&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Buffer: &lt;/span&gt;Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;Blocking Peptide:Cat.No. 4691P - GDF6 &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage: &lt;/span&gt;GDF6 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1.Cat.&lt;/span&gt; No. 1220 - SK-N-SH Cell Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity:&lt;/span&gt; H, M, R&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number: &lt;/span&gt;48475062&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; NP_001001557&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; (CT) Growth Differentiation Factor 6&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;References&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   1. &lt;/span&gt;Massague J. 1990. The transforming growth factor-beta family. Ann. Rev. Cell Biol. 6:597-641.&lt;br /&gt; &lt;span style="font-weight: bold;"&gt;  2.&lt;/span&gt; McPherron AC, Lawler AM, and Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387:83-90.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   3. &lt;/span&gt;Hanel ML and Hensey C. Eye and neural defects associated with loss of GDF6. BMC Dev. Biol. 2006; 6:43.&lt;br /&gt;  &lt;span style="font-weight: bold;"&gt; 4. &lt;/span&gt;Settle SH Jr., Rountree RB, Sinha A, et al. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev. Biol. 2003; 254:116-130.&lt;br /&gt;&lt;/span&gt;                                         &lt;/div&gt;                         &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-4615537482741340361?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blog.biosyn.com/feeds/4615537482741340361/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=3026027584095932250&amp;postID=4615537482741340361' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4615537482741340361'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3026027584095932250/posts/default/4615537482741340361'/><link rel='alternate' type='text/html' href='http://blog.biosyn.com/2011/06/gdf6-antibody.html' title='GDF6 Antibody'/><author><name>Jessica</name><uri>http://www.blogger.com/profile/08596638860628609450</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='31' src='http://4.bp.blogspot.com/_LNYbecFAJXI/SyxNLcDc1UI/AAAAAAAAANk/4KhEQLulPPQ/S220/logo.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3026027584095932250.post-7280304866315547348</id><published>2011-06-20T07:45:00.004-08:00</published><updated>2011-06-20T07:50:37.734-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Custom RNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Peptide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom PNA Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Constrained Nucleotide Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom Antibody Synthesis'/><category scheme='http://www.blogger.com/atom/ns#' term='Custom DNA Synthesis'/><title type='text'>GBL Antibody</title><content type='html'>&lt;div style="text-align: center;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Catalog/Antibodies/Signal_Transduction_Antibodies/Products/GBL_Antibody-4119.aspx"&gt;&lt;span style="font-weight: bold;"&gt;GBL Antibody&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;Catalog#&lt;span style="font-weight: bold;"&gt;:3495&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;GbetaL (G protein beta protein subunit-like) is a member of a signaling pathway that regulates mammalian cell growth in response to the presence of nutrients and growth factors (1). It binds to the kinase domain of TOR (Target of rapamycin, also known as mTOR), an evolutionarily conserved serine/threonine kinase that regulates cell growth and cell cycle through its ability to integrate signals from nutrient levels and growth factors (reviewed in 2). Rapamycin inhibits TOR resulting in reduced cell growth and reduced rates of cell cycle and cell proliferation (reviewed in 3). TOR is normally associated with GbetaL and an additional regulatory protein RAPTOR, allowing TOR to control protein biosynthesis (3). The binding of GbetaL to TOR stimulates TOR’s kinase activity towards downstream proteins such as RPS6K (ribosomal protein S6 kinase) and the translation factor 4E-BP1 which leads to increased protein translation and cell growth (3).&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="npdet_box2"&gt;                             &lt;div class="npdet_headtxt2"&gt;                                 &lt;span style="font-size:100%;"&gt;&lt;strong&gt;Additional Names: &lt;/strong&gt;GBL, G beta protein subunit-like&lt;/span&gt;&lt;/div&gt;                         &lt;/div&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5C3495.gif"&gt;&lt;img style="float: left; margin: 0pt 10px 10px 0pt; cursor: pointer; width: 111px; height: 153px;" src="http://www.biosyn.com/Images%5Cantibody%5C3495.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;b&gt;&lt;br /&gt;Description&lt;/b&gt;&lt;br /&gt;&lt;b&gt;Left:&lt;/b&gt;                                        &lt;/span&gt;&lt;span style="font-size:100%;"&gt; Western blot analysis of GbL in human brain cell lysate with GbL antibody at (A) 1 and (B) 2 µg/ml.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Below:&lt;/b&gt; Immunohistochemistry of GbL in mouse brain tissue with GbL antibody at 10 µg/ml.                                                                                &lt;br /&gt;&lt;br /&gt;&lt;b&gt;Other Product Images&lt;/b&gt;&lt;/span&gt;                                                                               &lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;a href="http://www.biosyn.com/Images%5Cantibody%5Cd_184.gif"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 268px; height: 202px;" src="http://www.biosyn.com/Images%5Cantibody%5Cd_184.gif" alt="" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-weight: bold;"&gt;Source:&lt;/span&gt;GbL antibody was raised against a 14 amino acid &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; from near the carboxy-terminus of human GbL.&lt;br /&gt;Purification: Affinity chromatography purified via &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;peptide&lt;/a&gt; column&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Clonality and Clone:&lt;/span&gt; This is a polyclonal antibody.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Host: &lt;/span&gt;GBL antibody was raised in rabbit.&lt;br /&gt;Please use anti-rabbit secondary&lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt; antibodies&lt;/a&gt;.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Immunogen:&lt;/span&gt; Human GbL / G beta protein subunit-like &lt;a style="font-weight: bold;" href="http://www.biosyn.com/PeptideOverview.aspx"&gt;Peptide&lt;/a&gt; (Cat. No. 3495P)&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Application: &lt;/span&gt;GbL antibody can be used for the detection of GbL by Western blot at 1 µg/ml.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Tested Application(s): &lt;/span&gt;E, WB, IHC&lt;br /&gt;Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Blocking Peptide:&lt;/span&gt;Cat. No. 3495P - GBL Peptide&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Long-Term Storage&lt;/span&gt;: GBL antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. &lt;a style="font-weight: bold;" href="http://www.biosyn.com/AntibodyOverview.aspx"&gt;Antibodies&lt;/a&gt; should not be exposed to prolonged high temperatures.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Positive Control:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;1. Cat.&lt;/span&gt; No. 1303 - Human Brain Tissue Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;2. Cat. &lt;/span&gt;No. 1403 - Mouse Brain Tissue Lysate&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Species Reactivity: &lt;/span&gt;H, M, R&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;GI Number: &lt;/span&gt;30411038&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Accession Number:&lt;/span&gt; AAH52292&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Short Description:&lt;/span&gt; a member of the TOR signaling pathway&lt;br /&gt;References&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   1.&lt;/span&gt; Kim D-H, Sarbassov DD, Ali SM, et al. GbetaL, a positive regulator of the Rapamycin-sensitive pathway required for the nutrient-sensitive interaction between Raptor and mTOR. Mol. Cell 2003; 11:895-904.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   2.&lt;/span&gt; Shamji AF, Ngheim P, and Schreiber SL. Integration of growth factor and nutrient signaling: implications for cancer biology. Mol. Cell 2003; 12:271-80.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;   3.&lt;/span&gt; Fingar DC and Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004; 23:3151-71.&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/3026027584095932250-7280304866315547348?l=blog.biosyn.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' 
